Document:

​

Exhibit 4.11
​
AMENDMENT NO. 2 TO
2016 LOAN AGREEMENT
​
AMENDMENT NO. 2 TO 2016 LOAN AGREEMENT (this “Amendment”) dated as of November 29, 2021 between:
​
		(1)
	TELECOM ARGENTINA S.A., a sociedad anónima organized and existing under the laws of the Republic of Argentina (the “Borrower”); and

​
		(2)
	INTERNATIONAL FINANCE CORPORATION, an international organization established by Articles of Agreement among its member countries including the Republic of Argentina (“IFC”).

​
WHEREAS, Telecom Personal S.A. (the “Original Borrower”) and IFC entered into a Loan Agreement dated October 5, 2016 (the “Original Loan Agreement”) under which IFC provided the A Loan and the B Loan (each as defined therein) to the Original Borrower;
​
WHEREAS, the A Loan and the B Loan were fully disbursed to the Original Borrower under the terms of the Original Loan Agreement;
​
WHEREAS, the Original Borrower merged with and into the Borrower, its parent company, and the Borrower was the surviving entity;
​
WHEREAS, the Borrower and IFC entered into an Amendment No. 1 to 2016 Loan Agreement dated September 17, 2020 amending the Original Loan Agreement (“Amendment No. 1”, and the Original Loan Agreement as amended by Amendment No. 1, the “Existing Loan Agreement”) providing primarily for the modification of the repayment schedule of all the principal amounts of the A Loan and B Loan due in 2021, which amendment was contingent upon a prepayment of the Loan in an amount equal to $15,000,000, among other conditions (the “2020 Prepayment”);
​
WHEREAS, the Borrower made the 2020 Prepayment and complied with the other conditions and therefore Amendment No. 1 became effective on September 22, 2020;
​
WHEREAS, the Borrower and IFC have agreed to modify the repayment schedule in the Existing Loan Agreement to reflect (a) the 2020 Prepayment and (b) the roll-over of certain installments of principal of the Loan payable on the Interest Payment Dates falling in the Financial Years following the 2021 Financial Year (primarily the B Loan and a portion of one installment of the A Loan) to extend the final maturity of the Loan, and to make certain other related amendments to the Existing Loan Agreement; and
​
WHEREAS, the parties hereto desire to amend the Existing Loan Agreement in order to provide for the foregoing and the other matters set forth herein, all as more fully described below.
​
NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is acknowledged by all parties hereto, the parties hereto agree to amend the Existing Loan Agreement as follows:
​
1.Defined Terms. Wherever used in this Amendment, unless otherwise defined herein, or unless the context shall otherwise require, the terms defined in the Existing Loan Agreement as amended hereby shall have the same meanings herein, and the following term shall have the following meaning:
​
“2021 Upfront Fee” means a fee in the amount of $1,397,500.
​
​

​

​

2.Amendments to the Existing Loan Agreement. Subject to Section 7 of this Amendment, the Existing Loan Agreement is hereby amended as set forth below.
​
		(a)
	Section 1.01 of the Existing Loan Agreement shall be amended by:

​
		(i)
	amending the definition of IFC Financing Documents to read in its entirety as follows:

​
“’IFC Financing Documents’ means, collectively, this Agreement, Amendment No. 1, Amendment No. 2, the 2020 Fee Letter, the 2021 Fee Letter, the Lender Fee Letter and the IFC Fee Letter;”;
​
(ii)amending the definition of Interest Payment Date to read in its entirety as follows:
​
“’Interest Payment Date’ means March 15 and September 15 in each year in any year and, in the case of the B Loan only, December 15, 2021;”;
​
(iii)amending the definition of Interest Period to read in its entirety as follows:
​
“’Interest Period’ means each period of 6 months in each case beginning on an Interest Payment Date and ending on the day immediately before the next following Interest Payment Date, except in the case of:
​
		(a)
	the first period applicable to the Disbursement when it means the period beginning on the date on which the Disbursement is made and ending on the day immediately before the next following Interest Payment Date; and

​
		(b)
	the following periods of 3 months (each, a “Rolled-Over Interest Period”):

​
		(i)
	beginning on the Interest Payment Date falling on September 15, 2021 and ending on December 14, 2021; and

​
		(ii)
	beginning on December 15, 2021 and ending on March 14, 2022;”;

​
(iv)amending the definition of Relevant Spread to read in its entirety as follows:
​
“’Relevant Spread’ means:
​
		(a)
	with respect to (i) the installments of principal of the A Loan payable on the Interest Payment Dates falling on March 15, 2023 and September 15, 2023 (for the avoidance of doubt, the Deferred Amount), 5% per annum, (ii) with respect to the installment of principal of the A Loan payable on the Interest Payment Date falling on March 15, 2027, 6.75% per annum, and (iii) for all other installments of principal of the A Loan, 4% per annum; and

		(b)
	with respect to the B Loan, 6.75% per annum;”; and

​
​

- 2 -
​
Amendment No. 2 to 2016 Loan Agreement

​

(v)adding thereto the following new defined terms in appropriate alphabetic order:
​
“’2021 Fee Letter’ means that certain letter agreement entered into by and between IFC and the Borrower dated on or about the date of Amendment No. 2, in which the Borrower confirms and agrees to pay IFC such fees as are set forth therein;”; and
​
“’Amendment No. 2’ means Amendment No. 2 to 2016 Loan Agreement dated as of November 29, 2021 between the Borrower and IFC;”.
​
(b)Subsections (a) and (b) of Section 2.05 (Repayment) of the Existing Loan Agreement each shall be amended to read in its entirety as follows, respectively:
​
“Section 2.05. Repayment. (a) Subject to Section 1.04 (Business Day Adjustment), the Borrower shall repay the A Loan on the following Interest Payment Dates and in the following amounts:
​
	​

	​

	​

	Interest Payment Date
	   
	Principal Amount Due

	​
	​
	​

	March 15, 2019
	​
	$12,500,000

	September 15, 2019
	​
	$12,500,000

	March 15, 2020
	​
	$12,500,000

	September 15, 2020
	​
	$12,500,000

	March 15, 2021
	​
	$0

	September 15, 2021
	​
	$0

	December 15, 2021
	​
	$0

	March 15, 2022
	​
	$12,500,000

	September 15, 2022
	​
	$12,500,000

	March 15, 2023
	​
	$10,625,000

	September 15, 2023
	​
	$9,625,000

	March 15, 2024
	​
	$0

	September 15, 2024
	​
	$0

	March 15, 2025
	​
	$0

	September 15, 2025
	​
	$0

	March 15, 2026
	​
	$0

	September 15, 2026
	​
	$0

	March 15, 2027
	​
	$1,000,000”; and

​
“(b)Subject to Section 1.04 (Business Day Adjustment), the Borrower shall repay the B Loan on the following Interest Payment Dates and in the following amounts:
​
	Interest Payment Date
	    
	Principal Amount Due

	​
	​
	​

	March 15, 2019
	​
	$37,500,000

	September 15, 2019
	​
	$37,500,000

	March 15, 2020
	​
	$37,500,000

	September 15, 2020
	​
	$37,500,000

	March 15, 2021
	​
	$0

	September 15, 2021
	​
	$0

	December 15, 2021
	​
	$46,203,750

	March 15, 2022
	​
	$0

​
​

- 3 -
​
Amendment No. 2 to 2016 Loan Agreement

​

​
	September 15, 2022
	​
	$0

	March 15, 2023
	​
	$0

	September 15, 2023
	​
	$0

	March 15, 2024
	​
	$15,401,250

	September 15, 2024
	​
	$15,401,250

	March 15, 2025
	​
	$15,401,250

	September 15, 2025
	​
	$15,401,250

	March 15, 2026
	​
	$12,348,750

	September 15, 2026
	​
	$12,348,750

	March 15, 2027
	​
	$6,243,750”.

​
(c)Section 2.06 (Prepayment) of the Existing Loan Agreement shall be amended by (i) amending subsection (d) and (ii) including a new subsection (g), each to read in its entirety as follows:
​
“(d)Subject to subsection (g) below, amounts of principal prepaid under this Section shall:
​
		(i)
	first be allocated by IFC pro rata between the A Loan and the B Loan in proportion to their respective principal amounts outstanding; and

​
		(ii)
	then be applied by IFC pro rata to all the respective outstanding installments of principal of the A Loan and the B Loan; provided, that the 2020 Prepayment Amount shall be applied pro rata only to the respective outstanding installments of principal payable in 2023; and provided further, that except in the case of the 2020 Prepayment Amount as set forth in the preceding proviso, no amounts of principal prepaid shall be applied to the respective outstanding installments of principal of the A Loan payable in 2023 unless and until such installments are the only remaining outstanding amounts of principal of the A Loan payable before the Interest Payment Date falling on March 15, 2027.”; and

​
“(g)Notwithstanding anything to the contrary in this Agreement, amounts of principal prepaid under this Section shall not be applied to the installment of principal of the A Loan payable on the Interest Payment Date falling on March 15, 2027 unless such prepayment is for the entire amount of the Loan outstanding.”.
​
(d)Subsection (b)(iv) of Section 2.07 (Fees) of the Existing Loan Agreement shall be amended to read in its entirety as follows:
​
“(iv)the fees specified in the 2020 Fee Letter and the 2021 Fee Letter; and”.
​
(e)Subsection (a) of Section 2.11 (Unwinding Costs) of the Existing Loan Agreement shall be amended to add reference to the new Rolled Over Interest Periods, to read in its entirety as follows:
​
“Section 2.11. Unwinding Costs. (a) If IFC or any Participant incurs any cost, expense or loss as a result of:
​
		(i)	the Borrower:

​
		(A)
	failing to borrow in accordance with a request for Disbursement made pursuant to Section 2.02 (Disbursement Procedure);

​

- 4 -
​
Amendment No. 2 to 2016 Loan Agreement

​

		(B)
	failing to prepay in accordance with a notice of prepayment;

​
		(C)
	prepaying all or any portion of the Loan on a date other than an Interest Payment Date; or

​
		(D)
	after acceleration of the Loan, paying all or a portion of the Loan on a date other than an Interest Payment Date; or

​
(ii)determining or implementing LIBOR for either of the Rolled-Over Interest Periods;
​
then the Borrower shall immediately pay to IFC the amount that IFC from time to time notifies to the Borrower in writing as being the amount of those costs, expenses and losses incurred, which shall be binding (unless the Borrower shows to IFC’s reasonable satisfaction that the determination involves manifest error).”.
​
(f)Subsection (e) of Section 3.01 (Representations and Warranties) of the Existing Loan Agreement shall be amended, to read in its entirety as follows:
​
“(e)No Amendments to Charter. The Charter of the Borrower or any Subsidiary has not been amended since December 11, 2020;”.
​
(g)Subsection (h) of Section 3.01 (Representations and Warranties) of the Existing Loan Agreement shall be amended, to read in its entirety as follows:
​
“(h)Financial Condition. Since December 31, 2015, neither the Borrower nor any of its Subsidiaries:
​
		(i)
	has suffered any change that has a Material Adverse Effect or incurred any substantial loss or liability, except for the losses disclosed in the financial statements of the Borrower for the periods ending on September 30, 2019, December 31, 2019, September 30, 2020, December 31, 2020 and June 30, 2021, respectively, and the additional losses incurred after such financial statements, which in none of such cases resulted in a Material Adverse Effect;

​
		(ii)
	has undertaken or agreed to undertake any substantial obligation that would have a Material Adverse Effect;”.

​
(h)Section 7.02. (Notices) of the Existing Loan Agreement shall be amended by amending the Borrower’s address for notices to read in its entirety as follows:
​
“For the Borrower:
​
	​
	​

	Telecom Argentina S.A.
	​

	General Hornos 690
	​

	C1272ACL,
	​

	Buenos Aires, Argentina
	​

	Facsimile: +54 -11-4968-3616
	​

	Attention: Mr. Máximo Ayerza, Mr. Matías Colombo.”.
	​

​
​

- 5 -
​
Amendment No. 2 to 2016 Loan Agreement

​

(i)Annex E (Subsidiaries) of the Existing Loan Agreement shall be replaced in its entirety by Schedule 1 hereto.
​
3.LIBOR Replacement. IFC and the Borrower shall use their commercially reasonable efforts to discuss and enter into amendments and other documentation necessary to incorporate into the Existing Loan Agreement (as modified by this Amendment) the benchmark replacement of LIBOR during the second half of 2022.
​
4.Representations and Warranties. (a) The Borrower hereby represents and warrants to IFC that:
​
		(i)
	other than with respect to Section 3.01(g) (Representations and Warranties) of the Existing Loan Agreement, the representations and warranties made in Article III of the Existing Loan Agreement, as amended hereby, are true and correct in all material respects as of the date of this Amendment (except to the extent any such representations and warranties are (A) already qualified by materiality, in which case such representations and warranties are true and correct in all respects, or (B) made only as of a specific date or time, in which case such representation or warranty shall be true and correct as of such date or time);

​
		(ii)
	this Amendment has been authorized by all necessary corporate or other action of the Borrower and duly executed and delivered by the Borrower, and constitutes the legal, valid and binding obligation of such Borrower enforceable against it in accordance with its terms; and

​
(iii)no Event of Default or Potential Event of Default has occurred and is continuing.
​
(b)The Borrower hereby acknowledges that (i) it has made the representations in subsection (a) above with the intention of inducing IFC to enter into this Amendment and (ii) IFC has entered into this Amendment on the basis of, and in full reliance on, each of such representations.
​
5.Payment of Fees. Without limiting the terms of the Existing Loan Agreement or the other IFC Financing Documents, on the date of this Amendment, in connection with the transactions contemplated by this Amendment the Borrower shall pay to IFC, in accordance with the payment provisions of the Existing Loan Agreement, the 2021 Upfront Fee and the fee payable pursuant to the 2021 Fee Letter.
​
6.Limited Amendment. The amendments set forth in Section 2 of this Amendment are limited to the specific terms set forth herein. For the avoidance of doubt and without limiting the generality of the foregoing, the parties agree that, other than as specifically provided for in this Amendment, no other change, amendment or consent with respect to the terms and provisions of any of the IFC Financing Documents is intended or contemplated hereby (which terms and provisions remain unchanged and in full force and effect other than as expressly set forth herein).
​
7.Effectiveness of Amendment. (a) This Amendment shall become effective upon the satisfaction of the following conditions, each in form and substance satisfactory to IFC:
​
(i)the execution and delivery hereof by each of the Borrower and IFC;
​
		(ii)
	acceptance of all the terms of this Amendment by all of the Participants in the B Loan under the Existing Loan Agreement (for the avoidance of doubt, without 

​

- 6 -
​
Amendment No. 2 to 2016 Loan Agreement

​

further amendments to the IFC Financing Documents and the agreements entered into between IFC and the Participants);
​
(iii)payment by the Borrower to IFC of:
​
		(A)
	the installment of principal of the B Loan payable on the Interest Payment Date falling on December 15, 2021, together with related accrued interest;

​
		(B)
	the 2021 Upfront Fee;

​
		(C)
	the fee payable pursuant to the 2021 Fee Letter;

​
		(D)
	any past arrears of the Loan and any fees and expenses due under the Existing Loan Agreement, to the extent not paid in connection with paragraph (A) above, as notified to the Borrower by IFC; and

​
		(E)
	IFC’s and the Participants’ costs and expenses incurred in relation to this Amendment and the changes to the repayment schedule contemplated hereby, as notified to the Borrower by IFC (including, for the avoidance of doubt, any applicable unwinding costs incurred by IFC and the Participants as a result of determining or implementing LIBOR for the Rolled-Over Interest Periods); and

​
		(iv)
	IFC’s receipt, in form and substance satisfactory to it, of (A) a legal opinion addressed to IFC from counsel to the Borrower in the Country, covering the Argentine law matters relating to the transactions contemplated by this Amendment as IFC may reasonably request, and (B) a legal opinion addressed to IFC from Becker, Glynn, Muffly, Chassin & Hosinski LLP, IFC’s special counsel in New York, covering the New York Law aspects of the transactions contemplated by this Amendment as IFC may reasonably request.

​
(b)IFC shall deliver a notice to the Borrower confirming satisfaction of the conditions under subsection (a) above. From and after the effectiveness thereof, the Existing Loan Agreement as hereby amended shall remain in full force and effect and is hereby ratified and confirmed in all respects. All references in the Existing Loan Agreement to “herein,” the “Agreement,” or similar terms shall refer to the Existing Loan Agreement as amended hereby.
​
(c)Any other provision hereof to the contrary notwithstanding, if this Amendment shall not have become effective by December 20, 2021, this Amendment shall be null and void and of no further effect, and the Existing Loan Agreement shall remain in full force and effect, unaffected hereby.
​
8.Counterparts. This Amendment may be executed in counterparts. Delivery of an executed counterpart of a signature page to this Amendment by facsimile or email shall constitute effective execution and delivery of this Amendment.
​
9.Governing Law; Jurisdiction. This Amendment shall be governed by and construed in accordance with the laws of the State of New York. The provisions set forth in Sections 7.05 (b) through (m) of the Existing Loan Agreement are hereby incorporated into this Amendment by reference, and for such purpose each reference therein to the “Agreement” shall be deemed to refer to this Amendment.
​
*signature page follows*
​
​

- 7 -
​
Amendment No. 2 to 2016 Loan Agreement

​

IN WITNESS WHEREOF, the parties have caused this Amendment to be signed in their respective names as of the date first above written.
​
	​

	​

	​
	TELECOM ARGENTINA S.A.

	​
	​

	​
	By: _/s/ MAXIMO AYERZA

	​
	Name: Máximo Ayerza

	​
	Title: Financial Director

​
​

- 8 -
​
Amendment No. 2 to 2016 Loan Agreement

​

	​

	​

	​
	INTERNATIONAL FINANCE CORPORATION

	​
	​

	​
	By: /s/ TENEL OKTEN

	​
	Name: Tenel Okten

	​
	Title: Portfolio Manager

​
​

- 9 -
​
Amendment No. 2 to 2016 Loan Agreement

​

Schedule 1
​
ANNEX E
SUBSIDIARIES
​
		i)
	Subsidiaries of the Borrower:

​
	Name
	Owner
	Ownership

	Inter Radios S.A.U.
	Telecom Argentina S.A.
	100.00%

	Cable Imagen S.R.L.
	Telecom Argentina S.A.
	100.00%

	Micro Sistemas S.A.U.
	Telecom Argentina S.A.
	100.00%

	Telecom Argentina USA Inc.
	Telecom Argentina S.A.
	100.00%

	Adesol S.A.
	Telecom Argentina S.A.
	100.00%

	Televisión Dirigida S.A.
	Telecom Argentina S.A.
	99.992%

	Televisión Dirigida S.A.
	PEM S.A.U.
	0.008%

	PEM S.A.U.
	Telecom Argentina S.A.
	100%

	Núcleo S.A.
	Telecom Argentina S.A.
	67.50%

	Personal Envíos S.A.
	Núcleo S.A.
	97.00%

	Personal Envíos S.A.
	Telecom Argentina S.A.
	2.00%

	Tuves Paraguay S.A.
	Núcleo S.A.
	99.99958%

	Tuves Paraguay S.A.
	Telecom Argentina S.A.
	0.00028%

	AVC Continente Audiovisual S.A.
	PEM S.A.U.
	40.00%

	AVC Continente Audiovisual S.A.
	Inter Radios S.A.U.
	20.00%

	AVC Continente Audiovisual S.A.
	Telecom Argentina S.A.
	40.00%

	Teledifusora San Miguel Arcángel S.A.
	Telecom Argentina S.A.
	49.10%

	Teledifusora San Miguel Arcángel S.A.
	Inter Radios S.A.U.
	1.00%

	La Capital Cable S.A.
	Telecom Argentina S.A.
	49.00%

	La Capital Cable S.A.
	Inter Radios S.A.U.
	1.00%

	Otamendi Cable Color S.A.
	La Capital Cable S.A.
	97.00%

	Otamendi Cable Color S.A.
	PEM S.A.U.
	1.5%

​

- 10 -
​
Amendment No. 2 to 2016 Loan Agreement

​

​
	Personal Smarthome S.A.
	Telecom Argentina S.A.
	90.00%

	Personal Smarthome S.A.
	PEM S.A.U.
	10.00%

	Opalker S.A.
	Telecom Argentina S.A.
	100%

​
		ii)
	Capital Stock in the Borrower:

​
​
	Name
	Owner
	Ownership of total capital stock

	Telecom Argentina S.A.
	Cablevisión Holding S.A.
	18.89% (Class D)

	Telecom Argentina S.A.
	VLG S.A.U.
	9.27% (Class D)

	Telecom Argentina S.A.
	Fintech Telecom LLC
	20.83% (Class A)

	Telecom Argentina S.A.
	Trust created on April 15, 2019
	21.84% (Class A and D)

	Telecom Argentina S.A.
	Free Float
	29.16% (Class B)

	Telecom Argentina S.A.
	Class C Shares
	0.01% (Class C)

	Cablevisión Holding S.A.
	GC Dominio S.A.
	26.44% (which represents 64.25% of the voting stock)

	VLG S.A.U.
	Cablevisión Holding S.A.
	100%

	Fintech Telecom LLC
	Fintech Holdings, Inc.
	100%

	Fintech Holdings, Inc.
	David Manuel Martínez Guzmán
	100%

​

- 11 -
​
Amendment No. 2 to 2016 Loan AgreementExhibit 10.1

 

ONDAS HOLDINGS INC.

$50,000,000

COMMON STOCK

EQUITY DISTRIBUTION AGREEMENT

 

March 22, 2022

 

Oppenheimer & Co. Inc.

85 Broad Street, 26th Floor

New York, New York 10004

Ladies and Gentlemen:

 

Ondas Holdings Inc., a Nevada
corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer
& Co. Inc., as follows:

 

1.
Issuance and Sale of Shares. The Company agrees that, from time to time during the term of this Agreement, on the terms
and subject to the conditions set forth herein, it may issue and sell to or through Oppenheimer & Co. Inc., acting as agent and/or
principal (the “Sales Agent”), shares of the Company’s common stock, par value $0.0001 per share (the
“Common Stock”), having an aggregate offering price of up to $50,000,000 (the “Maximum Amount”),
subject to the limitations set forth in Section 3(b) hereof. The issuance and sale of shares of Common Stock to or through the
Sales Agent will be effected pursuant to the Registration Statement (as defined below) filed, or to be filed, by the Company and after
such Registration Statement has been declared effective by the U.S. Securities and Exchange Commission (the “Commission”),
although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement (as defined below) to
issue the Common Stock.

 

On the date of this Agreement,
the Company has filed, or will file, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations
thereunder (collectively, the “Securities Act”), with the Commission, a registration statement on Form S-3,
including a base prospectus, relating to certain securities, including the Common Stock, to be issued from time to time by the Company,
and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities
Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the “Exchange Act”).
The Company has prepared a prospectus supplement specifically relating to the offer and sale of Placement Shares (as defined below) pursuant
to this Agreement included as part of such registration statement (the “ATM Prospectus”). The Company will furnish
to the Sales Agent, for use by the Sales Agent, copies of the ATM Prospectus included as part of such registration statement, relating
to the Placement Shares. Except where the context otherwise requires, such registration statement, as amended when it becomes effective,
including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus
(as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such
registration statement pursuant to Rule 430B or 462(b) of the Securities Act, is herein called the “Registration Statement.”
The base prospectus, including all documents incorporated therein by reference, and the ATM Prospectus, including all documents incorporated
therein by reference, each of which is included in the Registration Statement, as it or they may be supplemented by any additional prospectus
supplement, in the form in which such prospectus and/or ATM Prospectus have most recently been filed by the Company with the Commission,
is herein called the “Prospectus.” Any reference herein to the Registration Statement, the Prospectus or any
amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference
herein to the terms “amend,” “amendment” or “supplement” with respect to the Registration Statement
or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission deemed
to be incorporated by reference therein. For purposes of this Agreement, all references to the Registration Statement, the Prospectus
or to any amendment or supplement thereto shall be deemed to include any copy filed with the Commission pursuant to the Electronic Data
Gathering Analysis and Retrieval System or any successor thereto (collectively “EDGAR”).

 

    

     

    

 

2.
Placements. Each time that the Company wishes to issue and sell the Common Stock through the Sales Agent, as agent, hereunder
(each, a “Placement”), it will notify the Sales Agent by email notice (or other method mutually agreed to in
writing by the parties) (a “Placement Notice”) containing the parameters in accordance with which it desires
the Common Stock to be sold, which shall at a minimum include the number of shares of Common Stock to be issued (the “Placement
Shares”), the time period during which sales are requested to be made, any limitation on the number of shares of Common
Stock that may be sold in any one Trading Day (as defined in Section 3) and any minimum price below which sales may not be made,
a form of which containing such minimum sales parameters necessary is attached hereto as Schedule 1. The Placement Notice
shall originate from any of the individuals from the Company set forth on Schedule 2 (with a copy to each of the other individuals
from the Company listed on such schedule), and shall be addressed to each of the individuals from the Sales Agent set forth on Schedule
2, as such Schedule 2 may be amended from time to time. The Placement Notice shall be effective upon receipt by
the Sales Agent unless and until (i) in accordance with the notice requirements set forth in Section 4, the Sales Agent declines
to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Placement Shares have been
sold, (iii) in accordance with the notice requirements set forth in Section 4, the Company suspends or terminates the Placement
Notice, (iv) the Company issues a subsequent Placement Notice with parameters superseding those on the earlier dated Placement Notice,
or (v) this Agreement has been terminated under the provisions of Section 11. The amount of any discount, commission or other compensation
to be paid by the Company to the Sales Agent in connection with the sale of the Placement Shares through the Sales Agent, as agent, shall
be as set forth in Schedule 3. It is expressly acknowledged and agreed that neither the Company nor the Sales Agent will
have any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice
to the Sales Agent and the Sales Agent does not decline such Placement Notice pursuant to the terms set forth above, and then only upon
the terms specified therein and herein. In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice,
the terms of the Placement Notice will control.

 

3.
Sale of Placement Shares by the Sales Agent.

 

(a)
Subject to the terms and conditions herein set forth, upon the Company’s issuance of a Placement Notice, and unless the sale
of the Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement,
the Sales Agent, as agent for the Company, will use its commercially reasonable efforts consistent with its normal trading and sales practices
and applicable state and federal laws, rules and regulations and the rules of The Nasdaq Capital Market (the “Exchange”),
for the period specified in the Placement Notice, to sell such Placement Shares up to the amount specified by the Company in, and otherwise
in accordance with the terms of such Placement Notice. If acting as agent hereunder, the Sales Agent will provide written confirmation
to the Company (including by email correspondence to each of the individuals of the Company set forth on Schedule 2, if
receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply)
no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement
Shares hereunder setting forth the number of Placement Shares sold on such day, the compensation payable by the Company to the Sales Agent
pursuant to Section 2 with respect to such sales, and the Net Proceeds (as defined below) payable to the Company, with an itemization
of the deductions made by the Sales Agent (as set forth in Section 5(a)) from the gross proceeds that it receives from such sales.
Subject to the terms of the Placement Notice, the Sales Agent may sell Placement Shares by any method permitted by law deemed to be an
“at the market” offering as defined in Rule 415 under the Securities Act, including without limitation sales made directly
on the Exchange, on any other existing trading market for the Common Stock or to or through a market maker. If expressly authorized by
the Company in a Placement Notice, the Sales Agent may also sell Placement Shares in privately negotiated transactions. Subject to Section
3(c) below, the Sales Agent shall not purchase Placement Shares for its own account as principal unless expressly authorized to do
so by the Company in a Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance that the Sales Agent will
be successful in selling Placement Shares, and (ii) the Sales Agent will incur no liability or obligation to the Company or any other
person or entity if it does not sell Placement Shares for any reason other than a failure by the Sales Agent to use its commercially reasonable
efforts consistent with its normal trading and sales practices and applicable law and regulations to sell such Placement Shares as required
under this Section 3. For the purposes hereof, “Trading Day” means any day on which the Company’s
Common Stock is purchased and sold on the principal market on which the Common Stock is listed or quoted.

 

    2

     

    

 

(b)
Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares if, after giving effect to
the sale of such Placement Shares, the aggregate number or gross sales proceeds of Placement Shares sold pursuant to this Agreement would
exceed the lesser of: (i) the number or dollar amount of shares of Common Stock registered pursuant to the Registration Statement pursuant
to which the offering hereunder is being made, (ii) the number of authorized but unissued and unreserved shares of Common Stock, (iii)
the number or dollar amount of shares of Common Stock permitted to be offered and sold by the Company under Form S-3 (including General
Instruction I.B.1. of Form S-3, if and for so long as applicable), (iv) the number or dollar amount of shares of Common Stock authorized
from time to time to be issued and sold under this Agreement by the Company’s board of directors, a duly authorized committee thereof
or a duly authorized executive officer, and notified to the Sales Agent in writing, or (v) the number or dollar amount of shares of Common
Stock for which the Company has filed the ATM Prospectus or other prospectus or prospectus supplement thereto specifically relating to
the offering of the Placement Shares pursuant to this Agreement. Under no circumstances shall the Company cause or request the offer or
sale of any Placement Shares pursuant to this Agreement at a price lower than the minimum price authorized from time to time by the Company’s
board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to the Sales Agent in writing.
Notwithstanding anything to the contrary contained herein, the parties hereto acknowledge and agree that compliance with the limitations
set forth in this Section 3(b) on the number or dollar amount of Placement Shares that may be issued and sold under this Agreement
from time to time shall be the sole responsibility of the Company, and that the Sales Agent shall have no obligation in connection with
such compliance.

 

(c)
The Company acknowledges and agrees that the Sales Agent has informed the Company that the Sales Agent may, to the extent permitted
under the Securities Act and the Exchange Act (including, without limitation, Regulation M promulgated thereunder), purchase and sell
shares of Common Stock for its own account while this Agreement is in effect, and shall be under no obligation to purchase Placement Shares
on a principal basis pursuant to this Agreement, except as otherwise agreed by the Sales Agent in a Placement Notice; provided,
that no such purchase or sales shall take place while a Placement Notice is in effect (except (i) as agreed by the Company and the Sales
Agent in the Placement Notice or (ii) to the extent the Sales Agent may engage in sales of Placement Shares purchased or deemed purchased
from the Company as a “riskless principal” or in a similar capacity); and, provided, further, that the Sales
Agent acknowledges and agrees that, except as expressly set forth in a Placement Notice, any such transactions are not being, and shall
not be deemed to have been, undertaken at the request or direction of, or for the account of, the Company, and that the Company has and
shall have no control over any decision by the Sales Agent to enter into any such transactions.

 

(d)
During the term of this Agreement and notwithstanding anything to the contrary herein, the Sales Agent agrees that in no event
will the Sales Agent or its affiliates engage in any market making, bidding, stabilization or other trading activity with regard to the
Common Stock or related derivative securities if such activity would be prohibited under Regulation M or other anti-manipulation rules
under the Exchange Act.

 

    3

     

    

 

(e)
The Sales Agent represents and warrants that it is duly registered as a broker-dealer under the Financial Industry Regulatory Authority,
Inc. (“FINRA”) and the applicable statutes and regulations of each state in which the Placement Shares will
be offered and sold, except such states in which the Sales Agent is exempt from registration or such registration is not otherwise required
in connection with the offer and sale of the Placement Shares. The Sales Agent shall continue, for the term of this Agreement, to be duly
registered as a broker-dealer under FINRA and the applicable statutes and regulations of each state in which the Placement Shares will
be offered and sold, except such states in which it is exempt from registration or such registration is not otherwise required in connection
with the offer and sale of the Placement Shares.

 

4.
Suspension of Sales.

 

(a) The Company or the
Sales Agent may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the
other party set forth on Schedule 2, if receipt of such correspondence is actually acknowledged by any of the
individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile
transmission or email correspondence to each of the individuals of the other party set forth on Schedule 2), suspend
any sale of Placement Shares for a period of time (a “Suspension Period”); provided, however,
that such suspension shall not affect or impair either party’s obligations with respect to any Placement Shares sold hereunder
prior to the receipt of such notice. While a Suspension Period is in effect, any obligation under Sections 7(m), 7(n)
and  7(o) with respect to the delivery of certificates, opinions or comfort letters to the Sales Agent shall be
suspended. Each of the parties agrees that no such notice under this Section 4 shall be effective against the other unless it
is made to one of the individuals named on Schedule 2 hereto, as such schedule may be amended from time to time.
During a Suspension Period, the Company shall not issue any Placement Notices and the Sales Agent shall not sell any Placement
Shares hereunder. The party that issued a suspension notice shall notify the other party in writing of the Trading Day on which the
Suspension Period shall expire not later than twenty-four (24) hours prior to such Trading Day.

 

(b)
Notwithstanding any other provision of this Agreement, during any period in which the Company is in possession of material non-public
information, the Company and the Sales Agent agree that (i) no sale of Placement Shares will take place, (ii) the Company shall not request
the sale of any Placement Shares, and (iii) the Sales Agent shall not be obligated to sell or offer to sell any Placement Shares.

 

5.
Settlement.

 

(a)
Settlement of Placement Shares. Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement
Shares will occur on the second (2nd) Trading Day (or such earlier day as is industry practice for regular-way trading) following
the respective Point of Sale (as defined below) (each, a “Settlement Date”). The amount of proceeds to be delivered
to the Company on a Settlement Date against receipt of the Placement Shares sold (the “Net Proceeds”) will be
equal to the aggregate sales price received by the Sales Agent at which such Placement Shares were sold, after deduction for (i) the Sales
Agent’s discount, commission or other compensation for such sales payable by the Company pursuant to Section 2 hereof, (ii)
any other amounts due and payable by the Company to the Sales Agent hereunder pursuant to Section 7(g) (Expenses) hereof and (iii)
any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales. “Point of Sale”
means, for a Placement, the time at which an acquiror of Placement Shares entered into a contract, binding upon such acquiror, to acquire
such Placement Shares.

 

    4

     

    

 

(b)
Delivery of Placement Shares. On each Settlement Date, the Company will, or will cause its transfer agent to, electronically
transfer the Placement Shares being sold by crediting the Sales Agent’s or its designee’s account (provided the Sales Agent
shall have given the Company written notice of such designee prior to the Settlement Date) at The Depository Trust Company through its
Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto which
in all cases shall be freely tradable, transferable, registered shares in good deliverable form. On each Settlement Date, the Sales Agent
will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date.
The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver duly authorized Placement
Shares on a Settlement Date, in addition to and in no way limiting the rights and obligations set forth in Section 9(a) (Indemnification
and Contribution) hereto, the Company will (i) hold the Sales Agent, its directors, officers, members, partners, employees and agents
of the Sales Agent, each broker dealer affiliate of the Sales Agent, and each person, if any, who (A) controls the Sales Agent within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (B) is controlled by or is under common control with
the Sales Agent (each, a “Sales Agent Affiliate”), harmless against any loss, claim, damage, or reasonable expense
(including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company or its transfer
agent (if applicable) and (ii) pay to the Sales Agent any commission, discount, or other compensation to which it would otherwise have
been entitled absent such default.

 

6.
Representations and Warranties of the Company. The Company, on behalf of itself and its subsidiaries, represents and warrants
to, and agrees with, the Sales Agent that as of each Applicable Time (as defined in Section 22(a)):

 

(a)
Compliance with Registration Requirements. As of each Applicable Time other than the date of this Agreement, the Registration
Statement and any Rule 462(b) Registration Statement have been declared effective by the Commission under the Securities Act. The Company
has complied to the Commission’s satisfaction with all requests of the Commission for additional or supplemental information related
to the Registration Statement and the Prospectus. No stop order suspending the effectiveness of the Registration Statement or any Rule
462(b) Registration Statement is in effect and no proceedings for such purpose or pursuant to Section 8A of the Securities Act have been
instituted or are pending or, to the knowledge of the Company, are contemplated or threatened by the Commission. The Registration Statement
and the offer and sale of the Placement Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply
in all material respects with said Rule. In the section entitled “Plan of Distribution” in the ATM Prospectus, the Company
has named Oppenheimer & Co. Inc. as an agent that the Company has engaged in connection with the transactions contemplated by this
Agreement. The Company was not and is not an “ineligible issuer” as defined in Rule 405 under the Securities Act.

 

(b)
No Misstatement or Omission. As of (i) the time of filing of the Registration Statement and (ii) as of the date of this
Agreement, the Company was not an “ineligible issuer” in connection with the offering of the Placement Shares pursuant to
Rules 164, 405 and 433 under the Securities Act. The Company agrees to notify the Sales Agent promptly upon the Company becoming an “ineligible
issuer.” The Prospectus when filed will comply or complied and, as amended or supplemented, if applicable, will comply in all material
respects with the Securities Act and the Exchange Act. Each of the Registration Statement, any Rule 462(b) Registration Statement and
any post-effective amendment thereto, at the time it becomes effective, and as of each Applicable Time, if any, will comply in all material
respects with the Securities Act and the Exchange Act and did not and, as of each Applicable Time, if any, will not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
not misleading. The Prospectus, as amended or supplemented, as of its date, did not and, as of each Applicable Time, if any, will not
contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading. The representations and warranties set forth in the two immediately
preceding sentences do not apply to statements in or omissions from the Registration Statement, any Rule 462(b) Registration Statement,
or any post-effective amendment thereto, or the Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity
with information furnished to the Company in writing by the Sale Agent expressly for use therein. The parties hereto agree that the information
provided in writing by or on behalf of the Sales Agent expressly for use in the Registration Statement, any Rule 462(b) Registration Statement,
or any post-effective amendment thereto, or the Prospectus, or any amendments or supplements thereto, consists solely of the material
referred to in Schedule 4 hereto, as updated from time to time. There are no contracts or other documents required to be
described in the Prospectus or to be filed as exhibits to the Registration Statement which have not been described or filed as required.

 

    5

     

    

 

(c)
S-3 Eligibility. At the time the Registration Statement and any Rule 462(b) Registration Statement was or will be filed
with the Commission, at the time the Registration Statement and any Rule 462(b) Registration Statement was or will be declared effective
by the Commission, and at the time the Company’s most recent Annual Report on Form 10-K was filed with the Commission, the Company
met or will meet the then applicable requirements for the use of Form S-3 under the Securities Act, including, but not limited to, General
Instruction I.B.1. of Form S-3, if and for so long as applicable. The Company is not a shell company (as defined in Rule 405 under the
Securities Act) and has not been a shell company for at least 12 calendar months previously.

 

(d)
Documents Incorporated by Reference. The documents incorporated by reference in the Registration Statement and the Prospectus,
at the time they became effective or were filed with the Commission, as the case may be, complied in all material respects with the requirements
of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder, and none of such
documents contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, and any further
documents so filed and incorporated by reference in the Registration Statement and the Prospectus, when such documents become effective
or are filed with the Commission, as the case may be, will conform in all material respects to the requirements of the Securities Act
or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder and will not contain an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they are made, not misleading.

 

(e)
Free Writing Prospectuses. The Company has not, directly or indirectly, prepared, used or referred to any “free writing
prospectus” (as defined in Rule 405 under the Securities Act) and agrees with the Sales Agent that it will not make any offer relating
to the Placement Shares that would constitute a “free writing prospectus.”

 

(f)
Preparation of Financial Statements. The financial statements of the Company (including all notes and schedules thereto)
included in the Registration Statement and the Prospectus present fairly the financial position of the Company and its consolidated subsidiaries
at the dates indicated and the statement of operations, stockholders’ equity and cash flows of the Company and its consolidated
subsidiaries for the periods specified; and such financial statements and related schedules and notes thereto, and the unaudited financial
information filed with the Commission as part of the Registration Statement, have been prepared in conformity with generally accepted
accounting principles, consistently applied throughout the periods involved. The summary and selected financial data included in the Registration
Statement and the Prospectus, if any, present fairly the information shown therein as at the respective dates and for the respective periods
specified and have been presented on a basis consistent with the consolidated financial statements set forth in the Prospectus and other
financial information. The pro forma financial statements and the related notes thereto included in the Registration Statement and the
Prospectus present fairly the information shown therein, have been prepared in accordance with the Commission’s rules and guidelines
with respect to pro forma financial statements and have been properly compiled on the bases described therein, and the assumptions used
in the preparation thereof are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances
referred to therein. To the knowledge of the Company, the financial statements of American Robotics, Inc., a Delaware corporation (“American
Robotics”), set forth or incorporated by reference in the Registration Statement and the Prospectus comply in all material
respects with the applicable requirements of the Securities Act and fairly present in all material respects the financial condition of
the Company and its consolidated subsidiaries as of the dates indicated and the results of operations and changes in cash flows for the
periods therein specified; such financial statements have been prepared in conformity with generally accepted accounting principles consistently
applied throughout the periods involved.

 

    6

     

    

 

(g)
Independent Accountants for the Company. Rosenberg Rich Baker Berman, P.A. (the “Auditor”), whose
reports are filed with the Commission as part of the Registration Statement and the Prospectus, as applicable, is and, during the periods
covered by their reports, was, (x) an independent public accounting firm as required by the Securities Act, (y) a registered public accounting
firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”))
and (z) not in violation of the auditor independence requirements of the Sarbanes-Oxley Act.

 

(h)
Independent Accountants for American Robotics. To the Company’s knowledge, Turner, Stone & Company, LLP (“Turner
Stone”), whose reports are filed with the Commission as part of the Registration Statement and the Prospectus, as applicable,
is and, during the periods covered by their reports, was, (x) an independent public accounting firm as required by the Securities Act
with respect to American Robotics, (y) a registered public accounting firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act)
and (z) not in violation of the auditor independence requirements of the Sarbanes-Oxley Act.

 

(i)
Incorporation and Good Standing of the Company and its Subsidiaries. The Company and the subsidiaries are duly organized,
validly existing and in good standing under the laws of their respective jurisdictions of incorporation or organization and each such
entity has all requisite power and authority to carry on its business as is currently being conducted as described in the Registration
Statement and the Prospectus, and to own, lease and operate its properties. All of the issued shares of capital stock of, or other ownership
interests in, each subsidiary have been duly and validly authorized and issued and are fully paid and non-assessable and are owned, directly
or indirectly, by the Company, free and clear of any lien, charge, mortgage, pledge, security interest, claim, limitation on voting rights,
equity, trust or other encumbrance, preferential arrangement, defect or restriction of any kind whatsoever. The Company and each of its
subsidiaries is duly qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which the nature
of the business conducted by it or location of the assets or properties owned, leased or licensed by it requires such qualification, except
for such jurisdictions where the failure to so qualify individually or in the aggregate would not have a material adverse effect on the
assets, properties, condition, financial or otherwise, or in the results of operations, business affairs or business prospects of the
Company and its subsidiaries considered as a whole (a “Material Adverse Effect”); and to the Company’s
knowledge, no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing, or seeking to revoke, limit or
curtail, such power and authority or qualification. Except as described in the Registration Statement and the Prospectus, the Company
does not own or control, directly or indirectly, any corporation, association or other entity.

 

(j)
Shelf Renewal. The Registration Statement initially became effective within three years of the date hereof. If, immediately
prior to the third anniversary of the initial effective date of the Registration Statement, any of the Placement Shares remain unplaced
by the Sales Agent, the Company will, prior to that third anniversary file, if it has not already done so, a new shelf registration statement
relating to the Placement Shares, in a form satisfactory to the Sales Agent, will use its best efforts to cause such registration statement
to be declared effective within 180 days after that third anniversary, and will take all other action necessary or appropriate to
permit the offering, sale and placement of the Placement Shares to continue as contemplated in the expired Registration Statement. References
herein to the registration statement relating to the Placement Shares shall include such new shelf registration statement.

 

    7

     

    

 

(k)
All Necessary Permits, Etc. The Company and each of its subsidiaries has all requisite corporate power and authority, and
all necessary authorizations, approvals, consents, orders, licenses, certificates and permits of and from all governmental or regulatory
bodies or any other person or entity (collectively, the “Permits”), to own, lease and license its assets and
properties and conduct its business, all of which are valid and in full force and effect, except where the lack of such Permits, individually
or in the aggregate, would not have a Material Adverse Effect. The Company and each of its subsidiaries has fulfilled and performed in
all material respects all of its obligations with respect to such Permits and no event has occurred that allows, or after notice or lapse
of time would allow, revocation or termination thereof or results in any other material impairment of the rights of the Company thereunder.
Except as may be required under the Securities Act and state and foreign Blue Sky laws, no other Permits are required to enter into, deliver
and perform this Agreement and to issue and sell the Placement Shares.

 

(l)
Intellectual Property. The Company or its subsidiaries own or possess the valid right to use all (i) valid and enforceable
patents, patent applications, trademarks, trademark registrations, service marks, service mark registrations, Internet domain name registrations,
copyrights, copyright registrations, licenses, trade secret rights (“Intellectual Property Rights”) and (ii)
inventions, software, works of authorships, trademarks, service marks, trade names, databases, formulae, know how, Internet domain names
and other intellectual property (including trade secrets and other unpatented and/or unpatentable proprietary confidential information,
systems, or procedures) (collectively, “Intellectual Property Assets”) necessary to conduct its business as
currently conducted, and as proposed to be conducted and described in the Registration Statement and the Prospectus. The Company has not
received any notice of, nor is aware of, any infringement of or conflict with asserted rights of others with respect to any Intellectual
Property Rights or Intellectual Property Assets. Further, the Company has not received any opinion from its legal counsel concluding that
any activities of its business infringe, misappropriate, or otherwise violate, valid and enforceable Intellectual Property Rights of any
other person, and has not received written notice of any challenge, which is to its knowledge still pending, by any other person to the
rights of the Company with respect to any Intellectual Property Rights or Intellectual Property Assets owned or used by the Company. To
the Company’s knowledge, the Company’s business as now conducted does not give rise to any infringement of, any misappropriation
of, or other violation of, any valid and enforceable Intellectual Property Rights of any other person. All licenses for the use of the
Intellectual Property Rights described in the Registration Statement and the Prospectus are valid, binding upon, and enforceable by or
against the parties thereto in accordance to its terms. The Company has complied in all material respects with, and is not in breach nor
has received any asserted or threatened claim of breach of any Intellectual Property license, and the Company has no knowledge of any
breach or anticipated breach by any other person to any Intellectual Property license. No claim has been made against the Company alleging
the infringement by the Company of any patent, trademark, service mark, trade name, copyright, trade secret, license in or other intellectual
property right or franchise right of any person. The Company has taken all reasonable steps to protect, maintain and safeguard its Intellectual
Property Rights, including the execution of appropriate nondisclosure and confidentiality agreements. The consummation of the transactions
contemplated by this Agreement will not result in the loss or impairment of or payment of any additional amounts with respect to, nor
require the consent of any other person in respect of, the Company’s right to own, use, or hold for use any of the Intellectual
Property Rights as owned, used or held for use in the conduct of the business as currently conducted. The Company has at all times complied
with all applicable laws relating to privacy, data protection, and the collection and use of personal information collected, used, or
held for use by the Company in the conduct of the Company’s business. No claims have been asserted or threatened against the Company
alleging a violation of any person’s privacy or personal information or data rights and the consummation of the transactions contemplated
hereby will not breach or otherwise cause any violation of any law related to data privacy, data protection, or the collection and use
of personal information collected, used, or held for use by the Company in the conduct of the Company’s business. The Company takes
reasonable measures to ensure that such information is protected against unauthorized access, use, modification, or other misuse. The
Company has taken all necessary actions to obtain ownership of all works of authorship and inventions made by its employees, consultants
and contractors during the time they are or were employed by or under contract with the Company and which relate to the Company’s
business. All founders and key employees have signed confidentiality, non-disclosure and invention assignment agreements with the Company.

 

    8

     

    

 

(m)
Cybersecurity. (i)(x) To the knowledge of Company, there has been no security breach or other compromise of any Personal
Data (as defined herein) and/or any of the Company’s information technology and computer systems, networks, hardware, software used
to store and/or process any Personal Data (collectively, “IT Systems and Data”) and (y) the Company has not
been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or
other compromise to their IT Systems and Data; (ii) the Company is presently in compliance with all applicable laws or statutes and all
applicable judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies
and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data
from unauthorized use, access, misappropriation or modification, if any, except as would not, in the case of this clause (ii), individually
or in the aggregate, have a Material Adverse Effect; and (iii) the Company has implemented backup and disaster recovery technology consistent
with industry standards and practices. “Personal Data” means (i) a natural person’s name, street
address, telephone number, email address, photograph, social security number, bank information, or customer or account number; (ii) any
information which would qualify as “personally identifying information” under the Federal Trade Commission Act, as amended;
(iii) Protected Health Information as defined by Health Insurance Portability and Accountability Act, as amended; and (iv) any
other piece of information that identifies such natural person, or his or her family, or identifies a specific person’s health condition
or sexual orientation.

 

(n)
Title to Properties. Except as described in the Registration Statement and the Prospectus, the Company and each of its subsidiaries
has good and marketable title in fee simple to all real property, and good and marketable title to all other property owned by it, in
each case free and clear of all liens, encumbrances, claims, security interests and defects, except such as do not materially affect the
value of such property and do not materially interfere with the use made or proposed to be made of such property by the Company and its
subsidiaries. All property held under lease by the Company and its subsidiaries is held by them under valid, existing and enforceable
leases, free and clear of all liens, encumbrances, claims, security interests and defects, except such as are not material and do not
materially interfere with the use made or proposed to be made of such property by the Company and its subsidiaries.

 

(o)
No Material Adverse Change. Subsequent to the respective dates as of which information is given in the Registration Statement
and the Prospectus, (i) there has not been any event which could have a Material Adverse Effect; (ii) neither the Company nor any of its
subsidiaries has sustained any loss or interference with its assets, businesses or properties (whether owned or leased) from fire, explosion,
earthquake, flood or other calamity, including a health epidemic or pandemic outbreak of infectious disease (including without limitation,
a further outbreak or escalation of COVID-19 or any related/mutated form of COVID-19), whether or not covered by insurance, or from any
labor dispute or any court or legislative or other governmental action, order or decree which would have a Material Adverse Effect; and
(iii) since the date of the latest balance sheet included in the Registration Statement and the Prospectus, neither the Company nor its
subsidiaries has (A) issued any securities (other than plans disclosed in the Registration Statement and the Prospectus for securities
issued pursuant to employee benefit plans, qualified stock option plans or other employee compensation plans or pursuant to plans disclosed
in the Registration Statement and the Prospectus for outstanding options, rights or warrants) or incurred any liability or obligation,
direct or contingent, for borrowed money, except such liabilities or obligations incurred in the ordinary course of business, (B) entered
into any transaction (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as
a whole or (C) declared or paid any dividend or made any distribution on any shares of its stock or redeemed, purchased or otherwise acquired
or agreed to redeem, purchase or otherwise acquire any shares of its capital stock.

 

    9

     

    

 

(p)
Contracts and Agreements. There is no document, contract or other agreement required to be described in the Registration
Statement or the Prospectus or to be filed as an exhibit to the Registration Statement which is not described or filed as required by
the Securities Act or the Exchange Act, as applicable. Each description of a contract, document or other agreement in the Registration
Statement or the Prospectus accurately reflects in all respects the terms of the underlying contract, document or other agreement. Each
contract, document or other agreement described in the Registration Statement or the Prospectus or listed in the exhibits to the Registration
Statement or incorporated by reference is in full force and effect and is valid and enforceable by and against the Company or its subsidiary,
as the case may be, in accordance with its terms. Neither the Company nor any of its subsidiaries, if a subsidiary is a party, nor to
the Company’s knowledge, any other party is in default in the observance or performance of any term or obligation to be performed
by it under any such agreement, and no event has occurred which with notice or lapse of time or both would constitute such a default,
in any such case which default or event, individually or in the aggregate, would have a Material Adverse Effect. No default exists, and
no event has occurred which with notice or lapse of time or both would constitute a default, in the due performance and observance of
any term, covenant or condition, by the Company or its subsidiary, if a subsidiary is a party thereto, of any other agreement or instrument
to which the Company or any of its subsidiaries is a party or by which Company or its properties or business or a subsidiary or its properties
or business may be bound or affected which default or event, individually or in the aggregate, would have a Material Adverse Effect.

 

(q)
Statistical and Market Data. The statistical and market related data included in the Registration Statement or the Prospectus
are based on or derived from sources that the Company believes to be reliable and accurate.

 

(r)
Non-Contravention of Existing Instruments. Neither the Company nor any subsidiary (i) is in violation of its certificate
or articles of incorporation, by-laws, certificate of formation, limited liability company agreement, partnership agreement or other organizational
documents, (ii) is in default under, and no event has occurred which, with notice or lapse of time, or both, would constitute a default
under, or result in the creation or imposition of any lien, charge, mortgage, pledge, security interest, claim, limitation on voting rights,
equity, trust or other encumbrance, preferential arrangement, defect or restriction of any kind whatsoever, upon, any property or assets
of the Company or any subsidiary pursuant to, any bond, debenture, note, indenture, mortgage, deed of trust, loan agreement or other agreement
or instrument to which it is a party or by which it is bound or to which any of its properties or assets is subject or (iii) is in violation
of any statute, law, rule, regulation, ordinance, directive, judgment, decree or order of any judicial, regulatory or other legal or governmental
agency or body, foreign or domestic, except (in the case of clauses (ii) and (iii) above) for violations or defaults that could not (individually
or in the aggregate) reasonably be expected to have a Material Adverse Effect.

 

(s)
The Equity Distribution Agreement. This Agreement has been duly authorized, executed and delivered by the Company, and constitutes
a valid, legal, and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as rights
to indemnity hereunder may be limited by federal or state securities laws and except as such enforceability may be limited by bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting the rights of creditors generally, and subject to general principles
of equity. All necessary corporate action has been duly and validly taken by the Company to enter into this Agreement and to authorize,
issue and sell the Placement Shares as contemplated by this Agreement. This Agreement conforms in all material respects to the descriptions
thereof in the Registration Statement and the Prospectus.

 

(t)
No Further Authorizations or Approvals Required. Neither the execution, delivery and performance of this Agreement by the
Company nor the consummation of any of the transactions contemplated hereby (including, without limitation, the issuance and sale by the
Company of the Placement Shares) will give rise to a right to terminate or accelerate the due date of any payment due under, or conflict
with or result in the breach of any term or provision of, or constitute a default (or an event which with notice or lapse of time or both
would constitute a default) under, or require any consent or waiver under, or result in the execution or imposition of any lien, charge
or encumbrance upon any properties or assets of the Company or its subsidiaries pursuant to the terms of, any indenture, mortgage, deed
of trust or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which either the Company or
its subsidiaries or any of their properties or businesses is bound, or any franchise, license, permit, judgment, decree, order, statute,
rule or regulation applicable to the Company or any of its subsidiaries or violate any provision of the charter or by-laws of the Company
or any of its subsidiaries, except for such consents or waivers which have already been obtained and are in full force and effect.

 

    10

     

    

 

(u)
Capitalization. The Company has authorized and outstanding capital stock as set forth under the captions “Capitalization”
and “Description of Capital Stock” in the Registration Statement and the Prospectus. The certificates evidencing the Placement
Shares are in due and proper legal form and have been duly authorized for issuance by the Company. All of the issued and outstanding shares
of Common Stock have been duly and validly issued and are fully paid and nonassessable. There are no statutory preemptive or other similar
rights to subscribe for or to purchase or acquire any shares of Common Stock of the Company or any of its subsidiaries or any such rights
pursuant to its Certificate of Incorporation or by-laws or any agreement or instrument to or by which the Company or any of its subsidiaries
is a party or bound. The Placement Shares, when issued and sold pursuant to this Agreement, will be duly and validly issued, fully paid
and nonassessable and none of them will be issued in violation of any preemptive or other similar right. Neither the filing of the Registration
Statement nor the offering or sale of the Placement Shares as contemplated by this Agreement gives rise to any rights for or relating
to the registration of any shares of Common Stock or other securities of the Company. Except as disclosed in the Registration Statement
and the Prospectus, there is no outstanding option, warrant or other right calling for the issuance of, and there is no commitment, plan
or arrangement to issue, any share of stock of the Company or any of its subsidiaries or any security convertible into, or exercisable
or exchangeable for, such stock. The exercise price of each option to acquire Common Stock, stock bonus and other stock plans or arrangements
(each, a “Company Stock Option”) is no less than the fair market value of a share of Common Stock as determined
on the date of grant of such Company Stock Option. All grants of Company Stock Options were validly issued and properly approved by the
Board of Directors of the Company in material compliance with all applicable laws and regulatory rules or requirements, including all
applicable federal securities laws, and the terms of the plans under which such Company Stock Options were issued and were recorded on
the Company’s financial statements in accordance with GAAP, and no such grants involved any “back dating”, “forward
dating,” “spring loading” or similar practices with respect to the effective date of grant. The description of the Company
Stock Options and the options or other rights granted thereunder set forth in the Registration Statement and the Prospectus accurately
and fairly presents in all material respects the information required to be shown with respect to such plans, arrangements and awards.
The Common Stock and the Placement Shares conform in all material respects to all statements in relation thereto contained in the Registration
Statement and the Prospectus.

 

(v)
No Applicable Registration or Other Similar Rights. There are no persons with registration or other similar rights to have
any equity or debt securities registered for sale under the Registration Statement or included in the offering contemplated by this Agreement,
except for such rights as have been duly waived. Other than as set forth in this Agreement, no person has the right to act as an underwriter,
placement or sales agent or as a financial advisor to the Company in connection with the offer and sale of the Placement Shares hereunder,
whether as a result of the filing or effectiveness of the Registration Statement or the sale of the Placement Shares as contemplated hereby
or otherwise.

 

(w)
No Legal Proceedings. There are no legal or governmental proceedings pending to which the Company or any of its subsidiaries
is a party or of which any property of the Company or any of its subsidiaries is the subject which, if determined adversely to the Company
or any of its subsidiaries could individually or in the aggregate have a Material Adverse Effect; and, to the knowledge of the Company,
no such proceedings are threatened or contemplated by governmental authorities or threatened by others.

 

    11

     

    

 

(x)
No Labor Disputes. Neither the Company nor any of its subsidiaries is involved in any labor dispute nor, to the knowledge
of the Company, is any such dispute threatened, which dispute would have a Material Adverse Effect. The Company is not aware of any existing
or imminent labor disturbance by the employees of any of its principal suppliers or contractors which would have a Material Adverse Effect.
The Company is not aware of any threatened or pending litigation between the Company or its subsidiaries and any of its executive officers
which, if adversely determined, could have a Material Adverse Effect and has no reason to believe that such officers will not remain in
the employment of the Company.

 

(y)
Supplier, Customer and Distributor Relations. No supplier, customer or distributor of the Company has notified the Company
that it intends to discontinue or decrease the rate of business done with the Company, except where such discontinuation or decrease has
not resulted in and could not reasonably be expected to result in a Material Adverse Effect.

 

(z)
Related Party Transactions. No transaction has occurred between or among the Company or any of its subsidiaries and any
of the Company’s officers or directors, stockholders or five percent stockholders or any affiliate or affiliates of any such officer
or director or stockholder or five percent stockholders that is required to be described in and is not described in the Registration Statement
and the Prospectus.

 

(aa)
No Price Stabilization or Manipulation. The Company has not taken, nor will it take, directly or indirectly, any action
designed to or which might reasonably be expected to cause or result in, or which has constituted or which might reasonably be expected
to constitute, the stabilization or manipulation of the price of the Common Stock or any security of the Company, within the meaning of
Regulation M of the Exchange Act, to facilitate the sale or resale of the Common Stock.

 

(bb)
Tax Law Compliance. The Company and each of its subsidiaries has filed all federal, state, local and foreign tax returns
which are required to be filed through the date hereof, which returns are true and correct in all material respects or has received timely
extensions thereof, and has paid all taxes shown on such returns and all assessments received by it to the extent that the same are material
and have become due. There are no tax audits or investigations pending, which if adversely determined would have a Material Adverse Effect;
nor are there any material proposed additional tax assessments against the Company or any of its subsidiaries.

 

(cc)
Authorization of the Placement Shares. The Placement Shares have been duly authorized for listing on the Exchange.

 

(dd)
Exchange Listing. The Company has taken no action designed to, or likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act or the listing of the Common Stock on the Exchange, nor has the Company received any notification
that the Commission or the Exchange is contemplating terminating such registration or listing.

 

(ee)
Internal Controls and Procedures. The books, records and accounts of the Company and its subsidiaries accurately and fairly
reflect, the transactions in, and dispositions of, the assets of, and the results of operations of, the Company and its subsidiaries.
Except as described in the Registration Statement and the Prospectus, the Company and each of its subsidiaries maintains a system of “internal
control over financial reporting” sufficient to provide reasonable assurances that (i) transactions are executed in accordance with
management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is
permitted only in accordance with management’s general or specific authorization, (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences and (v) interactive
data in eXtensible Business Reporting Language included in the Registration Statement fairly presents the information called for in all
material respects and is prepared in accordance with the Commission’s rules and guidelines applicable thereto.

 

    12

     

    

 

(ff)
Disclosure Controls and Procedures. Except as described in the Registration Statement and the Prospectus, the Company has
established and maintains disclosure controls and procedures (as such term is defined in Rule 13a-15 under the Exchange Act), which: (i)
are designed to ensure that material information relating to the Company is made known to the Company’s principal executive officer
and its principal financial officer by others within the Company, particularly during the periods in which the periodic reports required
under the Exchange Act are required to be prepared; (ii) provide for the periodic evaluation of the effectiveness of such disclosure controls
and procedures at the end of the periods in which the periodic reports are required to be prepared; and (iii) are effective in all material
respects to perform the functions for which they were established. Except as described in the Registration Statement and the Prospectus,
based on the Company’s most recent evaluation of its internal controls over financial reporting pursuant to Rule 13a-15(c) of the
Exchange Act, the Company is not aware of (i) any material weakness or significant deficiency in the design or operation of internal controls
which could adversely affect the Company’s ability to record, process, summarize and report financial data or any material weaknesses
in internal controls; or (ii) any fraud, whether or not material, that involves management or other employees who have a role in the Company’s
internal controls over financial reporting.

 

(gg)
No “Prohibited Activities”. Except as described in the Registration Statement and the Prospectus and as preapproved
in accordance with the requirements set forth in Section 10A of the Exchange Act, the Auditor has not been engaged by the Company to perform
any “prohibited activities” (as defined in Section 10A of the Exchange Act).

 

(hh)
No Material Off-Balance Sheet Arrangements. There are no material off-balance sheet arrangements (as defined in Item 303
of Regulation S-K under the Securities Act) that have or are reasonably likely to have a material current or future effect on the Company’s
financial condition, revenues or expenses, changes in financial condition, results of operations, liquidity, capital expenditures or capital
resources.

 

(ii)
Audit Committee. The Company’s Board of Directors has, subject to the exceptions, cure periods and phase in periods
specified in the applicable stock exchange rules (“Exchange Rules”), validly appointed an audit committee to
oversee internal accounting controls whose composition satisfies the requirements of Listing Rule 5605 of The Nasdaq Stock Market and
the Board of Directors and/or the audit committee has adopted a charter that satisfies the requirements of Listing Rule 5605 of The Nasdaq
Stock Market. The audit committee has adopted a charter that complies in all material respects with the requirements of the Exchange Rules
and has reviewed the adequacy of its charter within the past twelve months.

 

(jj)
Sarbanes-Oxley Act. There is and has been no failure on the part of the Company or any of its directors or officers, in
their capacities as such, to comply with any provision of the Sarbanes-Oxley Act, including, without limitation, Section 402 related to
loans and Sections 302 and 906 related to certifications.

 

(kk)
Insurance. The Company and its subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as are customary in the businesses in which they are engaged or propose to engage after giving effect
to the transactions described in the Registration Statement and the Prospectus; all policies of insurance and fidelity or surety bonds
insuring the Company or any of its subsidiaries or the Company’s or its subsidiaries’ respective businesses, assets, employees,
officers and directors are in full force and effect; the Company and each of its subsidiaries are in compliance with the terms of such
policies and instruments in all material respects; and neither the Company nor any subsidiary of the Company has any reason to believe
that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from
similar insurers as may be necessary to continue its business at a cost that is not materially greater than the current cost. Neither
the Company nor any of its subsidiaries has been denied any insurance coverage which it has sought or for which it has applied.

 

    13

     

    

 

(ll)
Consents and Approvals. Each approval, consent, order, authorization, designation, declaration or filing of, by or with
any regulatory, administrative or other governmental body necessary in connection with the execution and delivery by the Company of this
Agreement and the consummation of the transactions herein contemplated required to be obtained or performed by the Company (except such
additional steps as may be required by the Financial Industry Regulatory Authority (“FINRA”) or may be necessary
to qualify the Placement Shares for placement by the Sales Agent under the state securities or Blue Sky laws) has been obtained or made
and is in full force and effect.

 

(mm)
No FINRA Affiliations. There are no affiliations with FINRA among the Company’s officers, directors or, to the knowledge
of the Company, any five percent or greater stockholder of the Company, except as set forth in the Registration Statement and the Prospectus
or otherwise disclosed in writing to the Sales Agent.

 

(nn)
Compliance with FINRA Rules. All of the information provided to the Sales Agent or to counsel for the Sales Agent by the
Company, its counsel, its officers and directors and the holders of any securities (debt or equity) or options to acquire any securities
of the Company in connection with the offering of the Placement Shares is true, complete, correct and compliant in all material respects
with FINRA’s rules, and any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules or NASD
Conduct Rules is true, complete, correct and compliant in all material respects.

 

(oo)
Compliance with Environmental Laws. (i) Each of the Company and each of its subsidiaries is in compliance in all material
respects with all rules, laws and regulations relating to the use, treatment, storage and disposal of toxic substances and protection
of health or the environment (“Environmental Law”) which are applicable to its business; (ii) neither the Company
nor its subsidiaries has received any notice from any governmental authority or third party of an asserted claim under Environmental Laws;
(iii) each of the Company and each of its subsidiaries has received all permits, licenses or other approvals required of it under applicable
Environmental Laws to conduct its business, except where the lack of such permits, licenses or other approvals, individually or in the
aggregate, would not have a Material Adverse Effect, and is in compliance, in all material respects, with all terms and conditions of
any such permit, license or approval; (iv) to the Company’s knowledge, no facts currently exist that will require the Company or
any of its subsidiaries to make future material capital expenditures to comply with Environmental Laws; and (v) no property which is or
has been owned, leased or occupied by the Company or its subsidiaries has been designated as a Superfund site pursuant to the Comprehensive
Environmental Response, Compensation of Liability Act of 1980, as amended (42 U.S.C. Section 9601, et. seq.) (“CERCLA”)
or otherwise designated as a contaminated site under applicable state or local law. Neither the Company nor any of its subsidiaries has
been named as a “potentially responsible party” under CERCLA. In the ordinary course of its business, the Company periodically
reviews the effect of Environmental Laws on the business, operations and properties of the Company and its subsidiaries, in the course
of which the Company identifies and evaluates associated costs and liabilities (including, without limitation, any capital or operating
expenditures required for clean-up, closure of properties or compliance with Environmental Laws, or any permit, license or approval, any
related constraints on operating activities and any potential liabilities to third parties). On the basis of such review, the Company
has reasonably concluded that such associated costs and liabilities would not, singly or in the aggregate, have a Material Adverse Effect.

 

    14

     

    

 

(pp)
Compliance with Laws. The Company and each of its subsidiaries (i) is in compliance, in all material respects, with
any and all applicable foreign, federal, state and local laws, rules, regulations, treaties, statutes and codes promulgated by any and
all governmental authorities (including pursuant to the Occupational Health and Safety Act) relating to the protection of human health
and safety in the workplace (“Occupational Laws”); (ii) has received all material permits, licenses or
other approvals required of it under applicable Occupational Laws to conduct its business as currently conducted; and (iii) is in
compliance, in all material respects, with all terms and conditions of any such permits, licenses or approvals. No action, proceeding,
revocation proceeding, writ, injunction or claim is pending or, to the Company’s knowledge, threatened against the Company or any
of its subsidiaries relating to Occupational Laws, and the Company does not have knowledge of any facts, circumstances or developments
relating to its operations or cost accounting practices that could reasonably be expected to form the basis for or give rise to such actions,
suits, investigations or proceedings.

 

(qq)
Company Not an “Investment Company”. The Company is not and, after giving effect to the offering and sale of
the Placement Shares and the application of proceeds thereof as described in the Registration Statement and the Prospectus, will not be
required to register as an “investment company” or an entity “controlled” by an “investment company”
within the meaning of the Investment Company Act of 1940, as amended (the “Investment Company Act”).

 

(rr)
Anti-Corruption Laws. Neither the Company nor any of its subsidiaries nor any director, officer or employee of the Company
or any of its subsidiaries nor any director, officer, agent, employee, affiliate or other person associated with or acting on behalf of
the Company or any of its subsidiaries has, directly or indirectly, (i) used any corporate funds for unlawful contributions, gifts, entertainment
or other unlawful expenses relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization
of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned
or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of
the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of any anti-bribery
laws, including but not limited to, any applicable law, rule or regulation of any locality, including but not limited to any law, rule
or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International Business
Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010,
or any other applicable law, rule or regulation of similar purpose and scope or anti-corruption law; or (iv) made, offered, agreed, requested
or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence
payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintained and enforced,
and will continue to maintain and enforce, policies and procedures designed to promote and ensure compliance with all applicable anti-bribery
and anti-corruption laws.

 

(ss)
Anti-Money Laundering Laws. The operations of the Company and its subsidiaries are and have been conducted at all times
in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act
of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money
Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or
any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending, or to the knowledge
of the Company, threatened.

 

(tt)
OFAC.(i) Neither the Company, nor any of its subsidiaries, directors, officers, or employees, nor, to the knowledge
of the Company, any agent or affiliate of the Company or any of its subsidiaries, or other person associated with or acting on behalf
of the Company or any of its subsidiaries is (i) currently the subject or the target of any sanctions administered or enforced by the
U.S. government (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”)
or the U.S. Department of State and including, without limitation, the designation as a “specially designated national” or
“blocked person”), the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant
sanctions authority (collectively, “Sanctions”), nor is (ii) located, organized or resident in a country or
territory that is the subject or the target of Sanctions, including, without limitation, Russia, the Crimea region of Ukraine, Cuba, Iran,
North Korea and Syria (each, a “Sanctioned Country”).

 

    15

     

    

 

		(ii)	The Company will not, directly or indirectly, use the proceeds of the offering of the Placement Shares
hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity
(i) to fund or facilitate any activities or business of or with any person that, at the time of such funding or facilitation, is the subject
or the target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner
that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor,
investor or otherwise) of Sanctions.

 

		(iii)	For the past five years, the Company and its subsidiaries have not engaged in and are not now engaged
in, and will not engage in, any dealings or transactions with any person that at the time of the dealing or transaction is or was the
subject or the target of Sanctions or with any Sanctioned Country.

 

		(iv)	The Company has implemented and maintains in effect policies and procedures designed to ensure compliance
by the Company, and the Company and its subsidiaries, and their respective directors, officers and employees, and to the knowledge of
the Company, the agents of the Company and its subsidiaries, are in compliance with all applicable Sanctions, and are not knowingly engaged
in any activity that would reasonably be expected to result in the Company being designated as the subject or target of Sanctions.

 

(uu)
No Integration. Except as described in the Registration Statement and the Prospectus, the Company has not sold or issued
any shares of Common Stock during the six-month period preceding the date of the Prospectus, including any sales pursuant to Rule 144A
under, or Regulations D or S of, the Securities Act, other than shares issued pursuant to employee benefit plans, qualified stock options
plans or other employee compensation plans or pursuant to outstanding options, rights or warrants. For the avoidance of doubt, the Company
has not sold or issued any securities that would be integrated with the offering of the Placement Shares contemplated by this Agreement
pursuant to the Securities Act or any interpretations thereof by the Commission.

 

    16

     

    

 

(vv)
ERISA. (i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act
of 1974, as amended (“ERISA”), for which the Company or any member of its “Controlled Group”
(defined as any entity, whether or not incorporated, that is under common control with the Company within the meaning of Section 4001(a)(14)
of ERISA or any entity that would be regarded as a single employer with the Company under Section 414(b), (c), (m) or (o) of the Internal
Revenue Code of 1986, as amended (the “Code”), would have any liability (each, a “Plan”)
has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including
but not limited to, ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of
the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a statutory or administrative exemption; (iii)
for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no Plan has failed (whether or
not waived), or is reasonably expected to fail, to satisfy the minimum funding standards (within the meaning of Section 302 of ERISA or
Section 412 of the Code) applicable to such Plan; (iv) no Plan is, or is reasonably expected to be, in “at risk status” (within
the meaning of Section 303(i) of ERISA) and no Plan that is a “multiemployer plan” within the meaning of Section 4001(a)(3)
of ERISA is in “endangered status” or “critical status” (within the meaning of Sections 304 and 305 of ERISA);
(v) the fair market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined based
on those assumptions used to fund such Plan); (vi) no “reportable event” (within the meaning of Section 4043(c) of ERISA and
the regulations promulgated thereunder) has occurred or is reasonably expected to occur; (vii) each Plan that is intended to be qualified
under Section 401(a) of the Code is so qualified, and nothing has occurred, whether by action or by failure to act, which would cause
the loss of such qualification; (viii) neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects
to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guarantee Corporation,
in the ordinary course and without default) in respect of a Plan (including a “multiemployer plan”, within the meaning of
Section 4001(a)(3) of ERISA); and (ix) none of the following events has occurred or is reasonably likely to occur: (A) a material increase
in the aggregate amount of contributions required to be made to all Plans by the Company or its Controlled Group affiliates in the current
fiscal year of the Company and its Controlled Group affiliates compared to the amount of such contributions made in the Company’s
and its Controlled Group affiliates’ most recently completed fiscal year; or (B) a material increase in the Company and its subsidiaries’
“accumulated post-retirement benefit obligations” (within the meaning of Accounting Standards Codification Topic 715-60) compared
to the amount of such obligations in the Company and its subsidiaries’ most recently completed fiscal year, except in each case
with respect to the events or conditions set forth in (i) through (ix) hereof, as would not, individually or in the aggregate, have a
Material Adverse Effect.

 

(ww)
Distribution of Offering Material by the Company. None of the Company, its directors or its officers has distributed, nor
will distribute, prior to the completion of the Sales Agent’s distribution of the Placement Shares, any offering material in connection
with the offering and sale of the Placement Shares other than the Prospectus or the Registration Statement.

 

(xx)
[Reserved.]

 

(yy)
No Forward Looking Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and
Section 21E of the Exchange Act) contained in the Registration Statement or the Prospectus has been made or reaffirmed without a reasonable
basis or has been disclosed other than in good faith.

 

(zz)
Brokers. Other than as contemplated by this Agreement, the Company has not incurred any liability for any finder’s
or broker’s fee or agent’s commission in connection with the execution and delivery of this Agreement or the consummation
of the transactions contemplated hereby.

 

(aaa)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof
by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors
of the Federal Reserve System or any other regulation of such Board of Governors.

 

(bbb)
Debt Securities. There are (and prior to each Applicable Time, will be) no debt securities, convertible securities or preferred
stock issued or guaranteed by the Company or any of its subsidiaries that are rated by a “nationally recognized statistical rating
organization,” as such term is defined in Section 3(a)(62) under the Exchange Act.

 

(ccc)
No Material Lending Relationships. The Company (i) does not have any material lending or other relationship with any banking
or lending affiliate of the Sales Agent and (ii) does not intend to use any of the proceeds from the sale of the Placement Shares to repay
any outstanding debt owed to any affiliate of the Sales Agent.

 

    17

     

    

 

(ddd)
Dividend Payments. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or
other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on
such subsidiary’s capital stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary
from the Company or from transferring any of such subsidiary’s properties or assets to the Company or any other subsidiary of the
Company.

 

(eee)
No Outstanding Loans or Other Indebtedness. There are no outstanding loans, advances (except normal advances for business
expenses in the ordinary course of business) or guarantees of indebtedness by the Company to or for the benefit of any of the officers
or directors of the Company or any of their respective family members, except as disclosed in the Prospectus. The Company has not directly
or indirectly extended or maintained credit, arranged for the extension of credit, or renewed an extension of credit, in the form of a
personal loan to or for any director or executive officer of the Company.

 

(fff)
No Reliance. The Company has not relied upon the Sales Agent or legal counsel for the Sales Agent for any legal, tax or
accounting advice in connection with the offering and sale of the Placement Shares.

 

(ggg)
Continuous Offering Agreements. Except for this Agreement, the Company is not party to any other equity distribution or
sales agency agreement or other similar arrangement with any other agent or any other representative in respect of any “at the market
offering” or other continuous equity offering transaction.

 

(hhh)
No Material Defaults. Neither the Company nor any of its subsidiaries has defaulted on any installment on indebtedness for
borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, could reasonably be
expected to result in a Material Adverse Change.

 

Any certificate signed by an officer of the Company
and delivered to the Sales Agent or to counsel for the Sales Agent pursuant to or in connection with this Agreement shall be deemed to
be a representation and warranty by the Company to the Sales Agent as to the matters set forth therein.

 

The Company acknowledges that the Sales Agent
and, for purposes of the opinions to be delivered pursuant to Section 7 hereof, counsel to the Company and counsel to the Sales
Agent, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.

 

7.
Covenants of the Company. The Company covenants and agrees with the Sales Agent that:

 

(a)
Registration Statement Amendments. After the date of this Agreement and during any period in which a Prospectus relating
to any Placement Shares is required to be delivered by the Sales Agent under the Securities Act (including in circumstances where such
requirement may be satisfied pursuant to Rule 172 under the Securities Act), (i) the Company will notify the Sales Agent promptly of the
time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference, has been filed with
the Commission and/or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission
for any amendment or supplement to the Registration Statement or Prospectus or for additional information, (ii) the Company will prepare
and file with the Commission, promptly upon the Sales Agent’s request, any amendments or supplements to the Registration Statement
or Prospectus that, in the Sales Agent’s reasonable opinion, may be necessary or advisable in connection with the distribution of
the Placement Shares by the Sales Agent (provided, however, that the failure of the Sales Agent to make such request shall
not relieve the Company of any obligation or liability hereunder, or affect the Sales Agent’s right to rely on the representations
and warranties made by the Company in this Agreement, and provided, further, that the only remedy the Sales Agent shall
have with respect to the failure to make such filing shall be to cease making sales under this Agreement until such amendment or supplement
is filed); (iii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus, other than documents
incorporated by reference, relating to the Placement Shares or a security convertible into the Placement Shares unless a copy thereof
has been submitted to the Sales Agent within a reasonable period of time before the filing and the Sales Agent has not reasonably objected
thereto (provided, however, that the failure of the Sales Agent to make such objection shall not relieve the Company of
any obligation or liability hereunder, or affect the Sales Agent’s right to rely on the representations and warranties made by the
Company in this Agreement, and provided, further, that the only remedy the Sales Agent shall have with respect to the failure
by the Company to obtain such consent shall be to cease making sales under this Agreement); (iv) the Company will furnish to the Sales
Agent at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration
Statement or Prospectus, except for those documents available via EDGAR; (v) the Company will cause each amendment or supplement to the
Prospectus, other than documents incorporated by reference, to be filed with the Commission as required pursuant to the applicable paragraph
of Rule 424(b) of the Securities Act (without reliance on Rule 424(b)(8) of the Securities Act) or, in the case of any documents incorporated
by reference, to be filed with the Commission as required pursuant to the Exchange Act, within the time period prescribed (the determination
to file or not file any amendment or supplement with the Commission under this Section 7(a), based on the Company’s reasonable
opinion or reasonable objections, shall be made exclusively by the Company).

 

    18

     

    

 

(b)
Notice of Commission Stop Orders. The Company will advise the Sales Agent, promptly after it receives notice or obtains
knowledge thereof, of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any
notice objecting to, or other order preventing or suspending the use of, the Prospectus, of the suspension of the qualification of the
Placement Shares for offering or sale in any jurisdiction, or of the initiation of any proceeding for any such purpose or any examination
pursuant to Section 8(e) of the Securities Act, or if the Company becomes the subject of a proceeding under Section 8A of the Securities
Act in connection with the offering of the Placement Shares; and it will promptly use its commercially reasonable efforts to prevent the
issuance of any stop order or to obtain its withdrawal if such a stop order should be issued. Until such time as any stop order is lifted,
the Sales Agent shall cease making offers and sales under this Agreement.

 

(c)
Delivery of Prospectus; Subsequent Changes. During any period in which a Prospectus relating to the Placement Shares is
required to be delivered by the Sales Agent under the Securities Act with respect to a pending sale of the Placement Shares (including
in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will comply with
all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates
all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections
13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If during such period any event occurs as a result of which
the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary
to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary
to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify the
Sales Agent to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration
Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance; provided,
however, that the Company may delay the filing of any amendment or supplement if, in the judgment of the Company, it is in the
best interest of the Company.

 

(d)
Listing of Placement Shares. During any period in which the Prospectus relating to the Placement Shares is required to be
delivered by the Sales Agent under the Securities Act with respect to a pending sale of the Placement Shares (including in circumstances
where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will use commercially reasonable efforts
to cause the Placement Shares to be listed on the Exchange and to qualify the Placement Shares for sale under the securities laws of such
jurisdictions as the Sales Agent reasonably designates and to continue such qualifications in effect so long as required for the distribution
of the Placement Shares; provided, however, that the Company shall not be required in connection therewith to qualify as
a foreign corporation or dealer in securities or file a general consent to service of process in any jurisdiction.

 

    19

     

    

 

(e)
Delivery of Registration Statement and Prospectus. The Company will furnish to the Sales Agent and its counsel (at the expense
of the Company) copies of (i) the Registration Statement and the Prospectus (including all documents incorporated by reference therein)
filed with the Commission on the date of this Agreement and (ii) all amendments and supplements to the Registration Statement or Prospectus
that are filed with the Commission during any period in which a Prospectus relating to the Placement Shares is required to be delivered
by the Sales Agent under the Securities Act (including all documents filed with the Commission during such period that are deemed to be
incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as the Sales Agent may from
time to time reasonably request and, at the Sales Agent’s request, will also furnish copies of the Prospectus to each exchange or
market on which sales of the Placement Shares may be made; provided, however, that the Company shall not be required to
furnish any document (other than the Prospectus) to the Sales Agent to the extent such document is available on EDGAR.

 

(f)
Earnings Statement. The Company will make generally available to its security holders and the Sales Agent as soon as practicable,
but in any event not later than 15 months after the end of the Company’s current fiscal quarter, an earnings statement of the Company
and its subsidiaries (which need not be audited) covering a 12-month period that complies with Section 11(a) and Rule 158 of the Securities
Act. The terms “earnings statement” and “make generally available to its security holders” shall have the meanings
set forth in Rule 158 under the Securities Act.

 

(g)
Expenses. The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated
in accordance with the provisions of Section 11 hereunder, will pay the following expenses all incident to the performance of its
obligations hereunder, including, but not limited to, expenses relating to (i) the preparation, printing and filing of the Registration
Statement and each amendment and supplement thereto, of each Prospectus and of each amendment and supplement thereto, (ii) the preparation,
issuance and delivery of the Placement Shares, including any stock or other transfer taxes and any stamp or other duties payable upon
the sale, issuance or delivery of the Placement Shares to the Sales Agent, (iii) the fees and disbursements of the counsel, accountants
and other advisors to the Company in connection with the transactions contemplated by this Agreement; (iv) the qualification of the Placement
Shares under securities laws in accordance with the provisions of Section 7(d) of this Agreement, including filing fees (provided,
however, that any fees or disbursements of counsel for the Sales Agent in connection therewith shall be paid by the Sales Agent
except as set forth in (ix) below), (v) the printing and delivery to the Sales Agent of copies of the Prospectus and any amendments or
supplements thereto, and of this Agreement, (vi) the fees and expenses incurred in connection with the listing or qualification of the
Placement Shares for trading on the Exchange, (vii) the fees and expenses of the transfer agent or registrar for the Common Stock; (viii)
filing fees and expenses, if any, of the Commission and the FINRA Corporate Financing Department (including, with respect to any required
review by FINRA, the fees and expenses of the Sales Agent’s counsel); and (ix) the Company shall reimburse the Sales Agent for the
fees and disbursements of the Sales Agent’s counsel in an amount not to exceed (a) $75,000 in connection with the execution and
delivery of this Agreement, and (b) thereafter, $10,000 on a quarterly basis, without the prior written consent of the Company (not to
be unreasonably withheld).

 

(h)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use
of Proceeds.”

 

    20

     

    

 

(i)
Notice of Other Sales. During the pendency of any Placement Notice given hereunder, the Company shall provide the Sales
Agent notice as promptly as reasonably possible before it offers to sell, contracts to sell, sells, grants any option to sell or otherwise
disposes of any shares of Common Stock (other than Placement Shares offered pursuant to the provisions of this Agreement) or securities
convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire Common Stock; provided, that such
notice shall not be required in connection with the (i) issuance, grant or sale of Common Stock, options or other rights to purchase or
otherwise acquire Common Stock, or Common Stock issuable upon the exercise of options or other equity awards, in each case granted pursuant
to any stock option, stock bonus or other stock or compensatory plan or arrangement, whether now in effect or hereafter implemented, (ii)
issuance of securities in connection with an acquisition, merger, or sale or purchase of assets, (iii) issuance or sale of Common Stock
upon conversion of securities or the exercise of warrants, options or other rights then in effect or outstanding, and disclosed in filings
by the Company available on EDGAR or otherwise in writing to the Sales Agent, and (iv) issuance or sale of Common Stock pursuant to any
dividend reinvestment and stock purchase plan that the Company has in effect or may adopt from time to time, provided that the
implementation of such new plan is disclosed to the Sales Agent in advance. If the Company notifies the Sales Agent under this Section
7(i) of a proposed sale of shares of Common Stock or Common Stock equivalents, the Sales Agent may suspend any offers and sales of
Securities under this Agreement for a period of time deemed appropriate by the Sales Agent.

 

(j)
Change of Circumstances. The Company will, at any time during a fiscal quarter in which the Company intends to tender a
Placement Notice or sell Placement Shares, advise the Sales Agent promptly after it shall have received notice or obtained knowledge thereof,
of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document provided
to the Sales Agent pursuant to this Agreement.

 

(k)
Due Diligence Cooperation. The Company will cooperate with any reasonable due diligence review conducted by the Sales Agent
or its agents in connection with the transactions contemplated hereby, including, without limitation, providing information and making
available documents and senior corporate officers, during regular business hours and at the Company’s principal offices, as the
Sales Agent may reasonably request.

 

(l)
Required Filings Relating to Placement of Placement Shares. The Company shall set forth in each Annual Report on Form 10-K
and Quarterly Report on Form 10-Q filed by the Company with the Commission in respect of any quarter in which sales of Placement Shares
were made by or through the Sales Agent under this Agreement, with regard to the relevant period, the amount of Placement Shares sold
to or through the Sales Agent, the Net Proceeds to the Company and the compensation payable by the Company to the Sales Agent with respect
to such sales of Placement Shares. To the extent that the filing of a prospectus supplement to the Prospectus with the Commission with
respect to any sales of Placement Shares becomes required under Rule 424(b) under the Securities Act, the Company agrees that, on or before
such dates as the Securities Act shall require, the Company will (i) file a prospectus supplement to the Prospectus with the Commission
under the applicable paragraph of Rule 424(b) under the Securities Act, which prospectus supplement will set forth, with regard to the
relevant period, the amount of Placement Shares sold to or through the Sales Agent, the Net Proceeds to the Company and the compensation
payable by the Company to the Sales Agent with respect to such Placement Shares, and (ii) deliver such number of copies of each such prospectus
supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange
or market. The Company shall afford the Sales Agent and its counsel with a reasonable opportunity to review and comment upon, shall consult
with the Sales Agent and its counsel on the form and substance of, and shall give due consideration to all such comments from the Sales
Agent or its counsel on, any such filing prior to the issuance, filing or public disclosure thereof; provided, however, that the Company
shall not be required to submit for review (A) any portion of any periodic reports filed with the Commission under the Exchange Act other
than the specific disclosure relating to any sales of Placement Shares and (B) any disclosure contained in periodic reports filed with
the Commission under the Exchange Act if it shall have previously provided the same disclosure for review in connection with a previous
filing.

 

    21

     

    

 

(m)
Representation Dates; Certificate. On or prior to the date the first Placement Notice is given hereunder and each time the
Company subsequently thereafter (i) amends or supplements the Registration Statement or the Prospectus relating to the Placement Shares
(other than (A) a prospectus supplement filed in accordance with Section 7(l) of this Agreement or (B) a supplement or amendment
that relates to an offering of securities other than the Placement Shares) by means of a post-effective amendment, sticker, or supplement
but not by means of incorporation of document(s) by reference to the Registration Statement or the Prospectus relating to the Placement
Shares; (ii) files an annual report on Form 10-K under the Exchange Act (including any Form 10-K/A containing amended financial information
or a material amendment to the previously filed Form 10-K); (iii) files a quarterly report on Form 10-Q under the Exchange Act; (iv) files
a report on Form 8-K containing amended financial information (other than an earnings release, to “furnish” information pursuant
to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification of certain
properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange Act (unless
the Sales Agent determines that the information contained in such Form 8-K is not material); or (v) sells Placement Shares to the Sales
Agent as principal at the Point of Sale pursuant to the applicable Placement Notice (each date of filing of one or more of the documents
and each other date referred to in clauses (i) through (v) shall be a “Representation Date”), the Company shall
furnish the Sales Agent within three (3) Trading Days after each Representation Date with a certificate, in the form attached hereto as
Exhibit 7(m). The requirement to provide a certificate under this Section 7(m) shall be waived for any Representation Date
occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company
delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring
Representation Date; provided, however, that such waiver shall not apply for any Representation Date on which the Company
files its annual report on Form 10-K. Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Shares following
a Representation Date when the Company relied on such waiver and did not provide the Sales Agent with a certificate under this Section
7(m), then before the Company delivers the Placement Notice or the Sales Agent sells any Placement Shares, the Company shall provide
the Sales Agent with a certificate, in the form attached hereto as Exhibit 7(m), dated the date of the Placement Notice.

 

(n) Legal Opinions.
On or prior to the date the first Placement Notice is given hereunder, the Company shall cause to be furnished to the Sales Agent the
written opinion and negative assurance of Akerman LLP, counsel for the Company (“Company Counsel”), and Snell
& Wilmer L.L.P., Nevada local counsel for the Company (“Nevada Local Counsel”), and the written opinions
of Pearl Cohen Zedek Latzer Baratz LLP, intellectual property counsel for the Company (“IP Counsel”), and Akerman
LLP, intellectual property counsel for American Robotics (“IP Counsel for American Robotics”), each in form
and substance reasonably satisfactory to the Sales Agent. Thereafter, within three (3) Trading Days after each Representation Date with
respect to which the Company is obligated to deliver a certificate pursuant to Section 7(m) for which no waiver is applicable
pursuant to Section 7(m), and not more than once per calendar quarter, the Company shall cause to be furnished to the Sales Agent
the written opinions and negative assurance of Company Counsel and Nevada Local Counsel and the written opinions of IP Counsel and IP
Counsel for American Robotics substantially in the form previously agreed between the Company and the Sales Agent, modified, as necessary,
to relate to the Registration Statement and the Prospectus as then amended or supplemented.

 

    22

     

    

 

(o)
Comfort Letters. On or prior to the date the first Placement Notice is given hereunder and within three (3) Trading Days
after each subsequent Representation Date with respect to which the Company is obligated to deliver a certificate pursuant to Section
7(m) for which no waiver is applicable pursuant to Section 7(m), the Company shall cause its Auditor and Turner Stone to furnish
the Sales Agent letters (the “Comfort Letters”), dated the date that such Comfort Letter is delivered, in form
and substance satisfactory to the Sales Agent, (i) confirming that they are an independent registered public accounting firm within the
meaning of the Securities Act, the Exchange Act and the rules and regulations of the PCAOB and are in compliance with the applicable requirements
relating to the qualification of accountants under Rule 2-01 of Regulation S-X of the Commission, (ii) stating, as of such date, the conclusions
and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants’ “comfort
letters” to the Sales Agent in connection with registered public offerings (the first such letter, the “Initial Comfort
Letter”) and (iii) updating the Initial Comfort Letter with any information that would have been included in the Initial
Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as
amended and supplemented to the date of such letter; provided, that such comfort letter delivered by Turner Stone shall only be
required on or prior to the date the first Placement Notice is given hereunder.

 

(p)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or
that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, or purchase the Placement Shares to be issued and
sold pursuant to this Agreement, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales
Agent.

 

(q)
Insurance. The Company and its subsidiaries shall maintain, or caused to be maintained, insurance in such amounts and covering
such risks as is reasonable and customary for the business in which it is engaged.

 

(r)
Compliance with Laws. The Company and each of its subsidiaries shall maintain, or cause to be maintained, all material permits,
licenses and other authorizations required by federal, state and local law and regulations in order to conduct their businesses as described
in the Registration Statement and the Prospectus, and the Company and each of its subsidiaries shall conduct their businesses, or cause
their businesses to be conducted, in substantial compliance with such permits, licenses and authorizations and with applicable laws and
regulations, except where the failure to maintain or be in compliance with such permits, licenses and authorizations could not reasonably
be expected to result in a Material Adverse Effect.

 

(s)
Investment Company Act. The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it
nor its subsidiaries is or, after giving effect to the offering and sale of the Placement Shares and the application of proceeds therefrom
as described in the Prospectus, will be, an “investment company” within the meaning of such term under the Investment Company
Act.

 

(t)
Securities Act and Exchange Act. The Company will use its best efforts to comply with all requirements imposed upon it by
the Securities Act and the Exchange Act as from time to time in force, so far as necessary to permit the continuance of sales of, or dealings
in, the Placement Shares as contemplated by the provisions hereof and the Prospectus.

 

(u)
No Offer to Sell. Other than the Prospectus, neither the Sales Agent nor the Company (including its agents and representatives,
other than the Sales Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication
(as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation
of an offer to buy Placement Shares hereunder.

 

    23

     

    

 

(v)
Sarbanes-Oxley Act. The Company and its subsidiaries will use their best efforts to comply with all effective applicable
provisions of the Sarbanes-Oxley Act.

 

(w)
New Registration Statement. If immediately prior to the third anniversary of the initial effective date of the Registration
Statement, any of the Placement Shares remain unsold, the sale of the Placement Shares under this Agreement shall automatically be suspended
unless and until the Company files a new shelf registration statement relating to the Placement Shares and such new registration statement
is declared effective by the Commission. References herein to the Registration Statement shall include such new shelf registration statement.
If any such new shelf registration statement becomes effective prior to the termination date of this Agreement, the Company agrees to
notify the Sales Agent of such effective date.

 

8.
Conditions to the Sales Agent’s Obligations. The obligations of the Sales Agent hereunder with respect to a Placement
will be subject to the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due
performance by the Company of its obligations hereunder, to the completion by the Sales Agent of a due diligence review satisfactory to
the Sales Agent in its reasonable judgment, and to the continuing satisfaction (or waiver by the Sales Agent in its sole discretion) of
the following additional conditions:

 

(a)
Registration Statement Effective. The Registration Statement shall be effective and shall be available for the sale of all
Placement Shares contemplated to be issued by any Placement Notice.

 

(b)
Securities Act Filings Made. The Company shall have filed with the Commission the ATM Prospectus pursuant to Rule 424(b)
under the Securities Act within the applicable time period prescribed for such filing by Rule 424(b) (without reliance on Rule 424(b)(8)
of the Securities Act). All other filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to
the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule
424.

 

(c)
No Material Notices. None of the following events shall have occurred and be continuing: (i) receipt by the Company or any
of its subsidiaries of any request for additional information from the Commission or any other federal or state governmental authority
during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or
supplements to the Registration Statement or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental
authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose;
(iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of
any of the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; (iv) the
occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material document
incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes
in the Registration Statement, related Prospectus or such documents so that, in the case of the Registration Statement, it will not contain
any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein not misleading and, that in the case of the Prospectus, it will not contain any materially untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading.

 

(d)
No Misstatement or Material Omission. The Sales Agent shall not have advised the Company that the Registration Statement
or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in the Sales Agent’s reasonable
opinion is material, or omits to state a fact that in the Sales Agent’s reasonable opinion is material and is required to be stated
therein or is necessary to make the statements therein not misleading.

 

    24

     

    

 

(e)
Material Changes. Except as contemplated in the Prospectus, or disclosed in the Company’s reports filed with the Commission,
there shall not have been any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or
any development that could reasonably be expected to result in a Material Adverse Effect, or any downgrading in or withdrawal of the rating
assigned to any of the Company’s securities (other than asset backed securities) by any rating organization or a public announcement
by any rating organization that it has under surveillance or review its rating of any of the Company’s securities (other than asset
backed securities), the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment
of the Sales Agent (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it
impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated by this
Agreement and the Prospectus.

 

(f)
Legal Opinions. The Sales Agent shall have received the opinions and negative assurances of Company Counsel and Nevada Local
Counsel and the written opinions of IP Counsel and IP Counsel for American Robotics required to be delivered pursuant Section 7(n)
on or before the date on which such delivery of such opinions and negative assurances is required pursuant to Section 7(n).

 

(g)
Sales Agent Counsel Legal Opinion. The Sales Agent shall have received from White & Case LLP, counsel for the Sales
Agent, on or before the date on which the delivery of the Company Counsel legal opinion is required pursuant to Section 7(n), such
negative assurances with respect to such matters as the Sales Agent may reasonably require, and the Company shall have furnished to such
counsel such documents as they request for enabling them to pass upon such matters.

 

(h)
Comfort Letters. The Sales Agent shall have received a Comfort Letter from the Auditor and Turner Stone required to be delivered
pursuant Section 7(o) on or before the date on which such delivery of such Comfort Letter is required pursuant to Section 7(o).

 

(i)
Representation Certificate. The Sales Agent shall have received the certificate required to be delivered pursuant to Section
7(m) on or before the date on which delivery of such certificate is required pursuant to Section 7(m).

 

(j)
Secretary’s Certificate. The Sales Agent shall have received a certificate, signed on behalf of the Company by its
corporate Secretary, certifying as to (i) the Certificate of Incorporation of the Company, (ii) the By-laws of the Company, (iii) the
resolutions of the Board of Directors of the Company (or a committee thereof) authorizing the execution, delivery and performance of this
Agreement and the issuance of the Placement Shares and (iv) the incumbency of the officers duly authorized to execute this Agreement and
the other documents contemplated by this Agreement.

 

(k)
No Suspension. Trading in the Common Stock shall not have been suspended on the Exchange and the Common Stock shall not
have been delisted from the Exchange.

 

(l)
Other Materials. On each date on which the Company is required to deliver a certificate pursuant to Section 7(m),
the Company shall have furnished to the Sales Agent such appropriate further opinions, certificates, letters and documents as the Sales
Agent may have reasonably requested. All such opinions, certificates, letters and other documents shall have been in compliance with the
provisions hereof. The Company will furnish the Sales Agent with such conformed copies of such opinions, certificates, letters and other
documents as the Sales Agent shall have reasonably requested.

 

    25

     

    

 

(m)
Approval for Listing. The Placement Shares shall have been approved for listing on the Exchange, subject only to notice
of issuance.

 

(n)
No Termination Event. There shall not have occurred any event that would permit the Sales Agent to terminate this Agreement
pursuant to Section 11(a).

 

(o)
FINRA. The Sales Agent shall have received a letter from the Corporate Financing Department of FINRA confirming that such
department has determined to raise no objection with respect to the fairness or reasonableness of the terms and arrangements related to
the sale of the Placement Shares pursuant to this Agreement.

 

9.
Indemnification and Contribution.

 

(a)
Company Indemnification. The Company agrees to indemnify and hold harmless the Sales Agent, the directors, officers, members,
partners, employees and agents of the Sales Agent each broker dealer affiliate of the Sales Agent, and each Sales Agent Affiliate, if
any, from and against any and all losses, claims, liabilities, expenses and damages (including, but not limited to, any and all reasonable
investigative, legal and other expenses incurred in connection with, and any and all amounts paid in settlement (in accordance with Section
9(c)) of, any action, suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified
party and any third party, or otherwise, or any claim asserted), as and when incurred, to which the Sales Agent, or any such person, may
become subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise,
insofar as such losses, claims, liabilities, expenses or damages arise out of or are based, directly or indirectly, on (x) any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement or the Prospectus or any amendment or
supplement thereto or in any free writing prospectus or in any application or other document executed by or on behalf of the Company or
based on written information furnished by or on behalf of the Company filed in any jurisdiction in order to qualify the Common Stock under
the securities laws thereof or filed with the Commission, (y) the omission or alleged omission to state in any such document a material
fact required to be stated in it or necessary to make the statements in it not misleading or (z) any breach by any of the indemnifying
parties of any of their respective representations, warranties and agreements contained in this Agreement; provided, however,
that this indemnity agreement shall not apply to the extent that such loss, claim, liability, expense or damage arises from the sale of
the Placement Shares pursuant to this Agreement and is caused directly by an untrue statement or omission made in reliance upon and in
strict conformity with written information relating to the Sales Agent and furnished to the Company by the Sales Agent expressly for inclusion
in any document as described in clause (x) of this Section 9(a). This indemnity agreement will be in addition to any liability
that the Company might otherwise have.

 

(b)
The Sales Agent Indemnification. The Sales Agent agrees to indemnify and hold harmless the Company and its directors and
each officer of the Company that signed the Registration Statement, and each person, if any, who (i) controls the Company within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act or (ii) is controlled by or is under common control with the Company
(each, a “Company Affiliate”) from and against any and all losses, claims, liabilities, expenses and damages
(including, but not limited to, any and all reasonable investigative, legal and other expenses incurred in connection with, and any and
all amounts paid in settlement (in accordance with Section 9(c)) of, any action, suit or proceeding between any of the indemnified
parties and any indemnifying parties or between any indemnified party and any third party, or otherwise, or any claim asserted), as and
when incurred, to which any such Company Affiliate, may become subject under the Securities Act, the Exchange Act or other federal or
state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise
out of or are based, directly or indirectly, on (x) any untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement or the Prospectus or any amendment or supplement thereto, or (y) the omission or alleged omission to state in any
such document a material fact required to be stated in it or necessary to make the statements in it not misleading; provided, however,
that this indemnity agreement shall apply only to the extent that such loss, claim, liability, expense or damage is caused directly by
an untrue statement or omission made in reliance upon and in strict conformity with written information relating to the Sales Agent and
furnished to the Company by the Sales Agent expressly for inclusion in any document as described in clause (x) of this Section 9(b),
which the Company acknowledges consists solely of the material referred to in Schedule 4 hereto, as updated from time to
time.

 

    26

     

    

 

(c)
Procedure. Any party that proposes to assert the right to be indemnified under this Section 9 will, promptly after
receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party
or parties under this Section 9, notify each such indemnifying party of the commencement of such action, enclosing a copy of all
papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that
it might have to any indemnified party otherwise than under this Section 9 and (ii) any liability that it may have to any indemnified
party under the foregoing provision of this Section 9 unless, and only to the extent that, such omission results in the forfeiture
of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies
the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects
by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified
party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory
to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense,
the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except
for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified
party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will
be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing
by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses
available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3)
a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying
party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified
party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after
receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel
will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection
with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges
of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All
such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly after the indemnifying party received
a written invoice relating to the fees, disbursements and other charges in reasonable detail. An indemnifying party will not, in any event,
be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall, without the prior
written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim,
action or proceeding relating to the matters contemplated by this Section 9 (whether or not any indemnified party is a party thereto),
unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising or
that may arise out of such claim, action or proceeding.

 

    27

     

    

 

(d)
Contribution. In order to provide for just and equitable contribution in circumstances in which the indemnification provided
for in the foregoing paragraphs of this Section 9 is applicable in accordance with its terms but for any reason is held to be unavailable
from the Company or the Sales Agent, the Company and the Sales Agent will contribute to the total losses, claims, liabilities, expenses
and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement
of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other
than the Sales Agent, such as persons who control the Company within the meaning of the Securities Act, officers of the Company who signed
the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and the Sales Agent
may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and
the Sales Agent on the other. The relative benefits received by the Company on the one hand and the Sales Agent on the other hand shall
be deemed to be in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received
by the Company bear to the total compensation received by the Sales Agent from the sale of Placement Shares on behalf of the Company.
If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution
shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but
also the relative fault of the Company, on the one hand, and the Sales Agent, on the other, with respect to the statements or omission
that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable
considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information
supplied by the Company or the Sales Agent, the intent of the parties and their relative knowledge, access to information and opportunity
to correct or prevent such statement or omission. The Company and the Sales Agent agree that it would not be just and equitable if contributions
pursuant to this Section 9(d) were to be determined by pro rata allocation or by any other method of allocation that does not take
into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss,
claim, liability, expense, or damage, or action in respect thereof, referred to above in this Section 9(d) shall be deemed to include,
for the purpose of this Section 9(d), any legal or other expenses reasonably incurred by such indemnified party in connection with
investigating or defending any such action or claim to the extent consistent with Section 9(c) hereof. Notwithstanding the foregoing
provisions of this Section 9(d), the Sales Agent shall not be required to contribute any amount in excess of the commissions received
by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section
9(d), any person who controls a party to this Agreement within the meaning of the Securities Act will have the same rights to contribution
as that party (and any officers, directors, members, partners, employees or agents of the Sales Agent and each broker dealer affiliate
of the Sales Agent will have the same rights to contribution as the Sales Agent), and each officer of the Company who signed the Registration
Statement and each director of the Company will have the same rights to contribution as the Company, subject in each case to the provisions
hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect
of which a claim for contribution may be made under this Section 9(d), will notify any such party or parties from whom contribution
may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other
obligation it or they may have under this Section 9(d) except to the extent that the failure to so notify such other party materially
prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant
to the last sentence of Section 9(c) hereof, no party will be liable for contribution with respect to any action or claim settled
without its written consent if such consent is required pursuant to Section 9(c) hereof.

 

    28

     

    

 

10.
Representations and Agreements to Survive Delivery. The indemnity and contribution agreements contained in Section 9
of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive,
as of their respective dates, regardless of (i) any investigation made by or on behalf of the Sales Agent, any controlling person of the
Sales Agent, or the Company (or any of their respective officers, directors, members or controlling persons), (ii) delivery and acceptance
of the Placement Shares and payment therefor or (iii) any termination of this Agreement.

 

11.
Termination.

 

(a) The Sales Agent shall
have the right by giving notice as hereinafter specified at any time to terminate this Agreement if (i) any Material Adverse Effect,
or any development that could reasonably be expected to result in a Material Adverse Effect has occurred that, in the reasonable judgment
of the Sales Agent, may materially impair the ability of the Sales Agent to sell the Placement Shares hereunder, (ii) the Company shall
have failed, refused or been unable to perform any agreement on its part to be performed hereunder; provided, however,
in the case of any failure of the Company to deliver (or cause another person to deliver) any certification, opinion, or letter required
under Sections 7(m), 7(n) or 7(o), the Sales Agent’s right to terminate shall not arise unless such failure
to deliver (or cause to be delivered) continues for more than thirty (30) days from the date such delivery was required, (iii) any other
condition of the Sales Agent’s obligations hereunder is not fulfilled, or (iv) any suspension or limitation of trading in the Placement
Shares or in securities generally on the Exchange shall have occurred (including automatic halt in trading pursuant to market-decline
triggers, other than those in which solely program trading is temporarily halted), or a major disruption of securities settlements or
clearing services in the United States shall have occurred, or minimum prices for trading have been fixed on the Exchange. Any such termination
shall be without liability of any party to any other party except that the provisions of Section 7(g) (Expenses), Section 9
(Indemnification and Contribution), Section 10 (Representations and Agreements to Survive Delivery), Section 11(f),
Section 16 (Applicable Law; Consent to Jurisdiction) and Section 17 (Waiver of Jury Trial) hereof shall remain in full
force and effect notwithstanding such termination. If the Sales Agent elects to terminate this Agreement as provided in this Section
11(a), the Sales Agent shall provide the required notice as specified in Section 12 (Notices).

 

(b)
The Company shall have the right, by giving ten (10) days’ notice as hereinafter specified in Section 12, to terminate
this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of
any party to any other party except that the provisions of Section 7(g), Section 9, Section 10, Section 11(f),
Section 16 and Section 17 hereof shall remain in full force and effect notwithstanding such termination.

 

(c)
The Sales Agent shall have the right, by giving ten (10) days’ notice as hereinafter specified in Section 12, to terminate
this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of
any party to any other party except that the provisions of Section 7(g), Section 9, Section 10, Section 11(f),
Section 16 and Section 17 hereof shall remain in full force and effect notwithstanding such termination.

 

(d)
Unless earlier terminated pursuant to this Section 11, this Agreement shall automatically terminate upon the issuance and
sale of all of the Placement Shares to or through the Sales Agent on the terms and subject to the conditions set forth herein; provided
that the provisions of Section 7(g), Section 9, Section 10, Section 11(f), Section 16 and Section
17 hereof shall remain in full force and effect notwithstanding such termination.

 

    29

     

    

 

(e)
This Agreement shall remain in full force and effect unless terminated pursuant to Sections 11(a), (b), (c)
or (d) above or otherwise by mutual agreement of the parties; provided, however, that any such termination by mutual
agreement shall in all cases be deemed to provide that Section 7(g), Section 9, Section 10, Section 11(f),
Section 16 and Section 17 shall remain in full force and effect.

 

(f)
Any termination of this Agreement shall be effective on the date specified in such notice of termination; provided, however,
that such termination shall not be effective until the close of business on the date of receipt of such notice by the Sales Agent or the
Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such termination
shall not become effective until the close of business on such Settlement Date and such Placement Shares shall settle in accordance with
the provisions of this Agreement.

 

12.
Notices. All notices or other communications required or permitted to be given by any party to any other party pursuant
to the terms of this Agreement shall be in writing, unless otherwise specified, and if sent to the Sales Agent, shall be delivered to:

 

Oppenheimer & Co. Inc.

85 Broad Street, 26 th
Floor

New York, New York 10004

Attention: Peter Vogelsang

E-mail: Peter.vogelsang@opco.com

 

with a copy (which shall not constitute notice)
to:

 

White & Case LLP

1221 Avenue of the Americas

New York, New York 10020

 

and if to the Company, shall be delivered to:

 

Ondas Holdings Inc.

411 Waverley Oaks Road, Suite 114 

Waltham, Massachusetts 02452

Attention: Eric Brock

Email: eric.brock@ondas.com

 

with a copy (which shall not constitute notice)
to:

 

Akerman LLP

350 East Las Olas Boulevard,
Suite 1600

Fort Lauderdale, Florida

Attention: Christina Russo

Email: christina.russo@akerman.com

 

Each party may change such
address for notices by sending to the other party to this Agreement written notice of a new address for such purpose. Each such notice
or other communication shall be deemed given (i) when delivered personally or by verifiable facsimile transmission on or before 4:30 p.m.,
New York City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business Day, (ii) on the next Business
Day after timely delivery to a nationally-recognized overnight courier and (iii) on the Business Day actually received if deposited in
the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, “Business
Day” shall mean any day on which the Exchange and commercial banks in the City of New York are open for business.

 

An electronic communication
(“Electronic Notice”) shall be deemed written notice for purposes of this Section 12 if sent to the electronic
mail address specified by the receiving party under separate cover. Electronic Notice shall be deemed received at the time the party sending
Electronic Notice receives confirmation of receipt by the receiving party (other than pursuant to auto-reply). Any party receiving Electronic
Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form (“Nonelectronic Notice”)
which shall be sent to the requesting party within ten (10) days of receipt of the written request for Nonelectronic Notice.

 

    30

     

    

 

13.
Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the Company and the Sales Agent
and their respective successors and permitted assigns and, as to Sections 5(b) and 9, the other indemnified parties specified therein.
References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party.
Nothing in this Agreement, express or implied, is intended to confer upon any other person any rights, remedies, obligations or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations
under this Agreement without the prior written consent of the other party; provided, however, that the Sales Agent may assign
its rights and obligations hereunder to an affiliate of the Sales Agent without obtaining the Company’s consent.

 

14.
Adjustments for Share Splits. The parties acknowledge and agree that all share-related numbers contained in this Agreement
shall be adjusted to take into account any share split, share dividend or similar event effected with respect to the Common Stock.

 

15.
Entire Agreement; Amendment; Severability. This Agreement (including all schedules and exhibits attached hereto and Placement
Notices issued pursuant hereto) and any other writing entered into by the parties relating to this Agreement constitutes the entire agreement
and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard
to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed
by the Company and the Sales Agent. In the event that any one or more of the provisions contained herein, or the application thereof in
any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall
be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms
and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but
only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with
the intent of the parties as reflected in this Agreement.

 

16.
Applicable Law; Consent to Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the internal
laws of the State of New York, without regard to the principles of conflicts of laws. Each party hereby irrevocably submits to the non-exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan, for the adjudication of any dispute
hereunder or in connection with any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding
is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof (certified
or registered mail, return receipt requested) to such party at the address in effect for notices to it under this Agreement and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law.

 

17.
Waiver of Jury Trial. The Company and the Sales Agent each hereby irrevocably waives any right it may have to a trial by
jury in respect of any claim based upon or arising out of this Agreement or any transaction contemplated hereby.

 

18.
Absence of Fiduciary Relationship. The Company acknowledges and agrees that:

 

(a)
the Sales Agent is acting solely as agent in connection with the sale of the Placement Shares contemplated by this Agreement and
the process leading to such transactions, and no fiduciary or advisory relationship between the Company or any of its respective affiliates,
stockholders (or other equity holders), creditors or employees or any other party, on the one hand, and the Sales Agent, on the other
hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether the Sales
Agent has advised or is advising the Company on other matters, and the Sales Agent has no obligation to the Company with respect to the
transactions contemplated by this Agreement, except the obligations expressly set forth in this Agreement;

 

    31

     

    

 

(b)
the Company is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions
contemplated by this Agreement;

 

(c)
the Sales Agent has not provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated
by this Agreement, and the Company has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate;

 

(d)
the Company has been advised and is aware that the Sales Agent and its affiliates are engaged in a broad range of transactions
which may involve interests that differ from those of the Company and that the Sales Agent has no obligation to disclose such interests
and transactions to the Company by virtue of any fiduciary, advisory or agency relationship; and

 

(e)
the Company waives, to the fullest extent permitted by law, any claims it may have against the Sales Agent, for breach of fiduciary
duty or alleged breach of fiduciary duty and agrees that the Sales Agent shall have no liability (whether direct or indirect, in contract,
tort or otherwise) to the Company in respect of such a fiduciary claim or to any person asserting a fiduciary duty claim on behalf of
or in right of the Company, including stockholders, partners, employees or creditors of the Company.

 

19.
Use of Information. The Sales Agent may not provide any information gained in connection with this Agreement and the transactions
contemplated by this Agreement, including due diligence, to any third party other than its legal counsel advising it on this Agreement
unless expressly approved by the Company in writing.

 

20.
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be
made by facsimile transmission or e-mail of a PDF attachment.

 

21.
Effect of Headings; Knowledge of the Company. The section and Exhibit headings herein are for convenience only and shall
not affect the construction hereof. All references in this Agreement to the “knowledge of the Company” or the “Company’s
knowledge” or similar qualifiers shall mean the actual knowledge of the directors and officers of the Company, after due inquiry.

 

22.
Definitions. As used in this Agreement, the following term has the meaning set forth below:

 

(a)
“Applicable Time” means the date of this Agreement, each Representation Date, each date on which a Placement
Notice is given, each Point of Sale, and each Settlement Date.

 

(b) “subsidiaries”
refer to Ondas Networks Inc. and American Robotics, Inc..

 

[Remainder
of Page Intentionally Blank]

 

    32

     

    

 

If the foregoing correctly
sets forth the understanding between the Company and the Sales Agent, please so indicate in the space provided below for that purpose,
whereupon this letter shall constitute a binding agreement between the Company and the Sales Agent.

 

	 	Very truly yours,
	 	 
	 	ONDAS HOLDINGS INC.
	 	 
	 	By: 	/s/ Eric Brock
	 	 	Name: 	Eric Brock
	 	 	Title:	Chief Executive Officer

 

	 	ACCEPTED as of the date first-above written:
	 	 
	 	OPPENHEIMER & CO. INC.
	 	
	 	By: 	/s/ Peter Bennett
	 	 	Name: 	Peter Bennett
	 	 	Title:	Managing Director

 

    33

     

    

 

Schedule
1

 

FORM OF PLACEMENT NOTICE

 

	From:	Ondas Holdings Inc.
	To:	Oppenheimer & Co. Inc.
	 	Attention:
	Subject:	At-The-Market Offering-Placement Notice

 

Gentlemen:

 

Pursuant to the terms and subject to the conditions
contained in the Equity Distribution Agreement between Ondas Holdings Inc., a Nevada corporation (the “Company”), and
Oppenheimer & Co. Inc. (the “Sales Agent”) dated March 22, 2022 (the “Agreement”), I
hereby request on behalf of the Company that the Sales Agent sell up to [____] shares of the Company’s common stock, par value $0.0001
per share, at a minimum market price of $[_______] per share, during the period beginning [MONTH/DAY/TIME] and ending [MONTH/DAY/TIME].

 

    34

     

    

 

Schedule
2

 

Notice Parties

 

Ondas Holdings Inc.

 

Eric Brock

 

Derek Reisfield

 

Oppenheimer & Co. Inc.

 

Peter Bennett

 

Chris DeFalco

 

John Hyland

 

Keith Clark

 

Victoria Lin

 

Garrett Meinhardt

 

Stephanie Cruz

 

Amanda Marquez

 

Allison Potter

 

Candice Lopez

 

Alison Christian

 

Brian Lang

 

Henry Alfaro

 

Mobasher Ahmed

 

Ethan Zak

 

    35

     

    

 

Schedule
3

 

Compensation

 

The Sales Agent shall be paid compensation equal
to 3.0% of the gross proceeds from the sales of Placement Shares pursuant to the terms of this Agreement and shall be reimbursed for certain
expenses in accordance with Section 7(g) of this Agreement.

 

The foregoing rate of compensation shall not apply
when the Sales Agent acts as principal, in which case the Company may sell the Placement Shares to the Sales Agent as principal at a price
agreed upon at the relevant Point of Sale pursuant to the applicable Placement Notice.

 

    36

     

    

 

Schedule
4

 

Information Provided By Sales Agent

 

The parties acknowledge and
agree that, for purposes of Sections 6(b) and 9 of this Agreement, there is no information provided by the Sales Agent.

 

The information in this Schedule
shall be updated from time to time in connection with the filing of a new Prospectus or otherwise as necessary.

 

    37

     

    

 

Exhibit 7(m)

 

OFFICER CERTIFICATE

 

The
undersigned, the duly qualified and appointed ____________________ of Ondas Holdings Inc., a Nevada corporation (the “Company”),
does hereby certify in such capacity and on behalf of the Company, pursuant to Section 7(m) of the Equity Distribution Agreement,
dated March 22, 2022 (the “Equity Distribution Agreement”), between the Company and Oppenheimer &
Co. Inc., that:

 

		(i)	the representations and warranties of the Company in Section 6 of the Equity Distribution Agreement
(A) to the extent such representations and warranties are subject to qualifications and exceptions contained therein relating to materiality
or Material Adverse Effect, are true and correct on and as of the date hereof with the same force and effect as if expressly made on and
as of the date hereof, except for those representations and warranties that speak solely as of a specific date and which were true and
correct as of such date, and (B) to the extent such representations and warranties are not subject to any qualifications or exceptions,
are true and correct in all material respects as of the date hereof as if made on and as of the date hereof with the same force and effect
as if expressly made on and as of the date hereof except for those representations and warranties that speak solely as of a specific date
and which were true and correct as of such date; and;

 

		(ii)	the Company has complied with all agreements and satisfied all conditions on its part to be performed
or satisfied pursuant to the Equity Distribution Agreement at or prior to the date hereof;

 

		(iii)	as of the date hereof, (i) the Registration Statement does not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading,
(ii) the Prospectus does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading and (iii)
no event has occurred as a result of which it is necessary to amend or supplement the Registration Statement or the Prospectus in order
to make the statements therein not untrue or misleading for clauses (i) and (ii) above, respectively, to be true and correct;

 

		(iv)	there has been no Material Adverse Effect since the date as of which information is given in the Prospectus,
as amended or supplemented;

 

		(v)	the Company does not possess any material non-public information; and

 

		(vi)	the aggregate offering price of the Placement Shares that may be issued and sold pursuant to the Equity
Distribution Agreement and the maximum number or amount of Placement Shares that may be sold pursuant to the Equity Distribution Agreement
have been duly authorized by the Company’s board of directors or a duly authorized committee thereof.

 

Terms used herein and not defined herein have
the meanings ascribed to them in the Equity Distribution Agreement.

 

	 	By: 	 
	 	 	Name:	 
	 	 	Title:	 

 

Date:

 

 

38

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]